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ABSTRACT
Numerous abandoned uranium mines (AUM) within the Navajo Nation contribute
uranium (U), arsenic (As) and other metals to the soil, air and groundwater that
continue to pose potential health risks to Navajo residents. The prevalence of
inflammatory-related cardiovascular disease (CVD) and type 2 diabetes (T2D)
has increased among the Navajo community in recent decades. Environmental
exposure to metal contaminants may alter the circulation in ways that are
associated with the inflammation-driven process of atherosclerotic plaque
formation. Thus, we hypothesize that exposures to AUM metal contaminants are
associated with pro-atherogenic changes in the circulation as evidenced by
increased low-density lipoprotein (LDL) oxidation and serum inflammatory
potential.
To assess the relative contribution of mining metals exposures on community
health, we assessed oxLDL and its relationship to CVD and T2D biomarkers in
the Navajo, and then these data were linked to mining contaminant exposure
metrics (water intake and urine metals). As proof-of-concept and to examine a
possible mechanism, acellular assays investigated if As and U could directly
oxidize purified human LDL cholesterol. Lastly, since serum represents the
balance of inflammation, i.e. inflammatory potential, transcriptional responses of
intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1
(VCAM-1), and chemokine (C-C motif) ligand (CCL2) were measured from
primary endothelial cells treated with participant serum. These responses were
linked to mining contaminant exposures (water intake and AUM proximity).
v

Regression modeling showed that estimated annual intake of As from drinking
water is a significant predictor of oxLDL in this population, despite oxLDL levels
being similar to levels in other populations without evidence of CVD. We found
that As, but not U, oxidized the protein but not the lipid components of LDL
cholesterol. Linear regression modeling showed that AUM proximity solely and
strongly predicted serum inflammatory potential as measured by endothelial cell
transcription of VCAM-1, ICAM-1 and CCL2.
Taken together, our data suggest that exposure to U mining waste in a
population with several CVD risk factors influences pro-atherogenic changes in
the circulation, and that other exposure routes, metals, and mixtures should be
investigated. Our data may aid in modifying clinical treatment decisions and
exposure reduction strategies.
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I. Chapter 1
INTRODUCTION
Communities of the Navajo Nation reside in a geographical area rich in uranium
ore. Natural deposits and historical mining activities have left a legacy of
abandoned uranium mines (AUM) and exposure risks from the remaining metal
contaminants. The Navajo have expressed ongoing concerns about how their
health may be affected by these contaminants. The high prevalence of
cardiovascular related health conditions, including type 2 diabetes (T2D) and
obesity, present in this vulnerable population may be exacerbated by mining
contaminants. Chronic, unalleviated exposures to contaminants such as those
present in mining wastes may result in changes in the circulation that interact
with the endothelium leading to permanent remodeling and worsening of disease.
To assess the potential impact of these contaminants on the cardiovascular
health of exposed individuals, we examined traditional (interleukin-6, IL6; Creactive protein, CRP) and novel oxidized low-density lipoprotein (oxLDL) plasma
cardiovascular disease (CVD) biomarkers as well as serum inflammatory
potential and linked these cardiovascular (CV) indicators to measures of
exposure including water intake and household proximity to AUM.
Epidemiology of Cardiovascular Disease
Cardiovascular disease is the leading cause of death globally, and according to
the World Health Organization (WHO 2015), approximately 17.5 million deaths in
2012 were due to CVDs, nearly one-third of all deaths worldwide. In the United
1

States, CVD has been the leading cause of death for the last 80 years and is a
major cause of disability with estimated costs in the U.S. exceeding $270 billion,
which is expected to triple by 2030 (Heidenreich et al. 2011). Nearly 7.4 million
of all worldwide CVD-related deaths were due to coronary artery disease (CAD)
(WHO 2015). Atherosclerosis is the principle cause of CAD. Risk factors include
hyperlipidemia, hypertension, obesity, diabetes, insulin resistance as well as
family history, age, poor nutrition, physical inactivity, and smoking. The
pathogenesis of atherosclerosis involves an imbalance in lipid metabolism and a
perpetual immune response leading to chronic inflammation of the arterial wall
(Weber and Noels 2011).

Cholesterol metabolism
Although a minimal amount of cholesterol comes from the diet, the liver forms
most cholesterol. Lipids absorbed from the intestine are packaged into
chylomicrons (large, triglyceride-rich particles), which undergo lipolysis to form
chylomicron remnants and are taken up by the liver. The liver secretes very lowdensity lipoproteins (VLDLs) (triglyceride-rich lipoproteins); this is the first step of
the endogenous lipoprotein pathway. VLDL are converted via intermediatedensity lipoproteins to low-density lipoprotein (LDL) or taken up by the liver.
High circulating levels of LDL are a risk factor for atherosclerosis. Normally, LDL
are removed from the circulation by the liver and other tissue cells via LDLreceptor-mediated endocytosis. Apolipoprotein B-100 (ApoB 100) is the major
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apolipoprotein carrier of chylomicrons, VLDL, intermediate density lipoprotein
and LDL (Dieplinger and Dieplinger 2012).

High density lipoprotein (HDL) cholesterol plays an important role in the reverse
transport of cholesterol from peripheral tissues to the liver. HDL is synthesized
by the liver and intestines, or from macrophages via cellular cholesterol efflux,
and then transported to the liver, i.e. reverse cholesterol transport, which is
important for removal of peripheral cholesterol. ApoA-I is the protein carrier for
HDL and helps mediate cholesterol efflux from macrophages via binding to ATP
Binding Cassette Transporter A1 (ABCA1) or scavenger receptor BI on
macrophages and takes up free cholesterol. During inflammation, cholesterol
efflux is reduced via inhibition of the liver x receptor (LXR) and retinoid x receptor
causing levels of circulating cholesterol to increase (Dieplinger and Dieplinger
2012).

Atherosclerosis and Inflammation
Atherosclerosis, the main cause of CAD, is the slow, chronic inflammatory
process by which lipids accumulate in the vascular intima leading to lesion
formation. The eventual rupture of the atherosclerotic lesion and resulting
thrombosis, and is the main cause of myocardial infarction and stroke. The
endothelium is the first cell type to encounter and respond to changes in the
circulation. Endothelial response to challenges (e.g. toxins) in the circulation is
largely driven by inflammatory cytokines (Ross e al. 1999). The initial response
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is an increase in the permeability of the arterial wall.. This disruption of the
endothelial barrier and formation of gaps between endothelial cells depend on
cytoskeletal changes (contractile elements including microfilaments and myosin)
(Kumar et al. 2009). Next, the endothelium is activated through receptormediated gene transcription of inflammatory cytokines (IL6, interleukin-8),
chemokines including chemokine (C-C motif) ligand (CCL2), adhesion molecules
including E-selectin, P-selectin, vascular cell adhesion molecule-1 (VCAM-1) and
intercellular adhesion molecule-1 (ICAM-1), which serve to recruit immune cells
(monocytes, T-cells) to the site of injury, and tissue factor (involved in
coagulation and fibrin formation). The result is transformation of the endothelium
from an anti-thrombotic to a pro-thrombotic phenotype (Ross 1999; Hunt and
Jurd 1998).

Monocytes extravasate into the vascular intima following a chemokine gradient
(chemotaxis) through the basement membrane and associating with the
extracellular matrix via integrin binding (Ross 1999). Monocytes differentiate into
macrophages once they move into tissue. Macrophages secrete cytokines,
reactive oxygen species, nitric oxide, proteases, and growth factors that promote
fibrosis and angiogenesis. Macrophages engulf LDL, especially oxidized LDL,
eventually forming foam cells. Foam cells in turn secrete inflammatory cytokines,
which trigger smooth muscle cell proliferation, lipid accumulation and plaque
formation, and eventual rupture of the fibrous cap and thrombosis (Weber and

4

Noels 2011). Eventual outcomes of this process are ischemia, myocardial
infarction and stroke.

Pathological changes and endothelial dysfunction may result if the activating
stimulus is unalleviated (Ross 1999). Homeostatic mechanisms of the
vasculature will eventually be unable to compensate, resulting in plaque
accumulation, vascular remodeling and clinical disease (Ross 1999), which may
be exacerbated when other independent risk factors (e.g. diabetes, hypertension
etc.) (Gutiérrez et al 2013) or environmental insults are present (e.g. air pollution,
metal contaminants) (Brook et al. 2010; Prozialeck et al. 2008), such as might
occur with chronic exposure to metals from mining waste.

Oxidized LDL
The LDL molecule is a complex arrangement of lipid components around a single
ApoB 100 molecule, a very large amphipathic protein (Segrest et al. 2001) which
contains 25 cysteine residues as part of its primary structure (Yang et al 1994).
The lipid components consist of an external phospholipid monolayer and free
cholesterol and a lipid core that contains cholesterol esters and triglycerides
(TG).

The oxidation of LDL is known to be involved in the initiation of atherosclerosis.
LDL is retained in the intima by binding of ApoB to the extracellular matrix (Lusis
et al. 2000). Oxidation of LDL may occur in the vessel wall, especially in
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atherosclerotic plaques; while circulating in the plasma; or even intracellularly
(Satoh and Tokunaga 2002), but the exact mechanisms and sites of oxidation
are not well understood (Itabe et al. 2011; Yoshida and Kisugi 2010). LDL may
be modified by enzymes (myeloperoxidase, lipoxygenase), reactive oxygen
species (ROS), reactive nitrogen species and metal ions (Yoshida and Kisugi
2010).

LDL can be minimally- or fully- oxidized, and modifications to LDL can be diverse
leading to differing effects. Minimally-modified LDL is still recognizable by the
LDL receptor (LDL-R). Fully-oxidized LDL is not recognized by LDL-R (Yoshida
and Kisugi 2010), but rather is recognized by scavenger receptors on endothelial
cells (Ox-LDL receptor 1, scavenger receptor A) and macrophages (scavenger
receptors A and B, and cluster of differentiation-36 receptor) (Zani et al. 2015),
which may be a result of evolutionary immune responses to “non-self” antigens.
The oxidation-specific epitopes such as those present on oxLDL are considered
danger-associated molecular patterns that are recognized by pattern recognition
receptors, such as cluster of differentiation 36 and toll-like receptor-4, resulting in
pro-inflammatory gene expression (nuclear kappa-factor-light-chain enhancer of
activated of B cells; NFκB and activator protein-1), antigen presentation, and lipid
uptake (Miller et al. 2011). OxLDL induces endothelial cell and macrophage
activation and triggers matrix metalloproteinases, surface expression of adhesion
molecules such as ICAM-1 and VCAM-1, and chemokines including CCL2
(Weber and Noels 2011).

6

CVD Biomarkers
Because CVD develops over a long periods of time (decades), but culminates in
life-threatening events such as myocardial infarction or stroke, the derivation of
personal risk factors for a CVD-related event have been a valuable prognostic
tool for physicians. While several non-modifiable risk factors are included in risk
calculations (age, gender, familial history), numerous biomarkers (CRP, IL6)
have also been examined as a potential means of improving the accuracy of
event predicting a CVD event.

Circulating oxLDL, a novel CVD biomarker, are associated with subclinical CVD
and metabolic syndrome (Holvoet et al. 2007) and are predictive of future
cardiovascular events (Holvoet et al 2004, Johnston et al. 2006, Meisinger et al.
2005). OxLDL is a major player in the development of atherosclerotic lesions
and, has not been assessed in any Native American population to date.

Epidemiology of CVD Native Americans
Native Americans generally are known to have a high prevalence of type 2
diabetes, metabolic syndrome, obesity and hypertension, which are all major risk
factors for CVD (Howard et al 1999, Hoy et al 1995, Sugarman et al 1990, Welty
et al 1995). CAD, hypertension and diabetes rates in Native Americans exceed
those of the general U.S. population (Centers for Disease Control, CDC, 2011,
2014; Galloway 2002; Howard et al. 1999). Findings from the Navajo Health and
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Nutrition Survey, conducted in the 1990s, also concluded that the Navajo
population has a high prevalence of overweight, diabetes, and hypertension
(Percy et al. 1997, White et al. 1997, Will et al.1997).

In the 1980s, the Strong Heart Study (SHS) began assessing cardiovascular
disease and its risk factors in 13 Native populations from Arizona, North and
South Dakota, and Oklahoma since (Lee et al.1990). The Pima Indians of
Arizona have a high prevalence of T2D, insulin resistance and obesity, but a
lower disposition for atherosclerosis relative to the native communities studied in
Oklahoma and North and South Dakota (Howard et al. 1995), and the incidence
of fatal coronary artery (heart) disease was less than half that found in the
Framingham population after controlling for age, sex, and diabetes, which has
been suggested to be due in part to lower LDL levels (Nelson et al. 1990; Weyer
et al. 2002). Many Native communities, including Navajo (Coulehan et al.1986),
have historically had lower incidences of myocardial infarction, ischemic heart
disease, and LDL levels (Becker et al. 1988; Sievers et al. 1968) in comparison
to the general population despite a high prevalence of diabetes, obesity and
hypertension, but more recently CAD has been on the rise (Klain et al. 1988;
Mendlein et al.1997; Sugarman et al. 1992), especially in those with diabetes
(Howard et al. 1999; Xu et al. 2012).

Inflammation plays a significant role in the pathogenesis CV-related conditions
including atherosclerosis, CAD, obesity, diabetes, and hypertension. CRP is a
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well-established inflammatory marker that is elevated in CVD, T2D, and obesity.
Only a handful of studies have looked at inflammation in Native American
communities. The SHS found that CRP was predictive of CVD in these
populations, especially in women but not in those with type 2 diabetes (Best et al.
2005). In Pima Indians, CRP and ICAM-1 were increased with increasing
adiposity and ICAM-1 and E-selectin were associated with insulin resistance
(Weyer et al. 2002). IL6 is a cytokine that is increased in inflammation and
causes the release of CRP. A polymorphism in the IL6 promoter is associated
with type 2 diabetes in Caucasians and Pima Indians (Vozarova et al. 2003),
although in another longitudinal study, circulating markers of inflammation (CRP,
IL6) and endothelial function (ICAM1, VCAM1) were not associated with the
development of diabetes in Pima Indians (Krakoff et al. 2003). Little information
exists on CVD-related inflammatory or endothelial markers in Native populations,
especially Navajo.

Uranium Mining on the Navajo Nation
The Navajo Nation is located on the Colorado Plateau, an area rich in the mineral
carnotite, a significant source of U. Carnotite (K2(UO2)2(VO4)23H2O), consists
of approximately 53% U, 11% vanadium (V) and trace amounts of radium. (Dias
de Cunha et al. 2014) Early Navajo and Ute Indians are said to have used the
red and yellow ores as body paint. Soon after the discovery of radium by Marie
and Pierre Curie in 1898, radium began to be mined from this region. (US
Environmental Protection Agency, EPA, 2008, 2013). This was followed by V
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mining in the 1920s, first for its uses in steel and then in the armament industry
during WWII. With the arrival of the Atomic age, U was extensively mined
starting in the mid-1940s. The U mined from the northern area of this region was
used for the atomic bomb.

Exposure sources
Nearly four million tons of high grade U ore was extracted in the Grants U District
on and near the Navajo Nation during mining operations from 1944 to 1986
under lease agreements with the Navajo Nation, leaving behind a legacy of over
500 AUMs, four U processing mills, 1,100 mine features (e.g. portals, prospects,
rim strips, pits, vertical shafts or waste piles), and hundreds of contaminated
wells (U.S. Environmental Protection Agency, US EPA, 2008, 2013). In the mid1990’s the Navajo Nation AUM regions became a part of the EPA’s Superfund
Program. The Diné Network for Environmental Health (DiNEH) Project, using a
culturally appropriate community-based participatory approach, originally began
addressing community concerns about the high rate of kidney disease in this
population and was later expanded to address broader health risks including
CVD in this exposed population. The DiNEH Project is a partnership of the
University of New Mexico Community Environmental Health Program, Southwest
Research and Information Center, Crownpoint Service Unit, University of TexasHouston Medical Center and communities from 20 Chapters of the Eastern
Navajo Agency.
Exposure pathways
10

Much of the metals contamination of water, soil, air and local biota is known to
occur from mining and milling sites, rather than from naturally present U deposits
(Mkandawire et al. 2013). U mine wastes consist of toxic metals, metalloids, and
remains of U, as well as ground rock particles, non-extracted radionuclides, and
leach and mill chemicals. Metals such as Arsenic (As), lead, cadmium, and
mercury are discharged into water and air pathways via the leaching process and
through blowing dust (Mkandawire et al. 2013). Transport of metals through the
environment is strongly influenced by their chemical form. More soluble forms
can move down through soil into underlying groundwater. (Argonne National
Laboratories (ANL) 2005). Water is a major exposure pathway for metals and
metalloids, as well as an important transport pathway for environmental
mobilization and redistribution of contaminants (Csavina et al. 2012). Up to 30%
of the population on the Navajo Nation does not have access to a public water
system (US EPA 2008).

Metals and metalloids typically adhere to soils of finer particle size near mining
operations can be suspended in air as atmospheric particulates (Csavina et al.
2012). These movements through air can contaminate soils, water and biota in
distant regions over long periods of time. Climate change may increase
exposure risks due to increased evaporation of contaminated water and
increased wind erosion uncovering previously buried sites (US Department of
Agriculture 2008). Some metals including U are absorbed much more readily if
inhaled than ingested (ANL 2005). Residents living near a petrochemical
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complex in Taiwan had urine levels of As and V that correlated with airborne
particulate matter suggesting a distance-to-source gradient (Yuan et al. 2015).

Traditional agricultural practices (livestock and crops) and use of native plants in
ceremonial practices may be potential sources of ingested contaminants,
although there has been a significant decline in agriculture in recent decades
(Diné Policy Institute. 2014). Uranium tends to adhere to soil particles, with soil
concentrations typically higher than in water. Nickel (Ni) also adheres to soil and
is not usually a major contaminant in groundwater (ANL 2005). Uranium can bioconcentrate in certain agricultural crops and in some land animals (Mkandawire
et al. 2013). Many plant species can take up As whereby it enters the food chain
(Zhao et al. 2010). Arsenic does not seem to bio-accumulate in animals.
Children are highly susceptible to ingestion of contaminated soils due to “handto-mouth” behaviors typical of their age. Urine concentrations of metals in
children have been found to correlate with soil concentrations near metal
smelters (Hwang et al. 1997).

Metabolism of Metals
Metals exposures occur mainly through ingestion, but can also occur via
inhalation and dermal routes. Metabolism of metals is an attempt by the body to
reduce toxicity, although, as in the case of As, this sometimes can serve to
produce more toxic species (Jomova and Valko 2011). The speciation or
oxidation state and solubility are also important factors in toxicity (Crans et al.
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2013). The most common physiological sources tested for metals exposure
include blood, urine, hair, and nails, as these are readily obtainable. The focus
for this project is on As and U because they are the major water contaminants in
the Navajo Nation, but other metals, such as Ni, V and copper (Cu), as well as
metals mixtures, may contribute to health effects.

Uranium
Uranium exists in different oxidation states and in other compounds, and
solubility is an important factor in exposure. Uranium is mostly ingested and is
excreted before it can enter the bloodstream. Based on a biokinetic model and
bone-ash samples from Health Canada, the absorption fraction of U from the
gastrointestinal tract was shown to be approximately 2% in adults, which is
mostly distributed in the bone and kidneys. (Chen 2011, ANL 2005). The total
body burden of U in humans has been estimated to be 40 µg, with nearly 10% of
this being present in the blood (ANL 2005; Igarashi et al. 1987). U in blood is
about 40% plasma bound and the remainder is found as the soluble uranyl ion.
(Briner et al. 2006). In the circulation, U is associated primarily with erythrocytes
(Fisenne and Perry 1985). Uranium forms a complex with albumin in equilibrium
with another complex formed with carbonate (Moss 1985). Uranyl compounds
have a high affinity for phosphate, carboxyl and hydroxyl groups, and therefore
can easily and stably bind with proteins and nucleotides. Inhalation of U can
result in a small proportion being deposited in the deep lung where it may remain
for several years and may also enter the bloodstream if the U is in a soluble form
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(ANL 2005). Inhaled lead and U dust both have pulmonary half-lives of about 4–5
years. (Briner et al. 2006)
Arsenic
As exists in organic and inorganic forms, as well as in different valence or
oxidation states, most commonly trivalent (III) and pentavalent (V). Inorganic As
is soluble and most commonly found in drinking water. About 95% of ingested
As is absorbed and about 40%-60% of Inhaled As is absorbed (Solenkova et al.
2014). Inorganic As is readily taken up by cells (Cohen et al. 2006; Hughes et al.
2011). As in the trivalent oxidation state (III) are considered to be the most toxic.
As(III) is primarily metabolized by the liver via progressive methylation which may
involve glutathione into a number of different species including
monomethylarsonic acid (MMA) and dimethylarsinic acid (DMA) (and other less
common but more toxic thioAsal) (Chen et al. 2013, Raml et al. 2007; Stea
2014). Most excreted As in the urine is in the form of DMA, some as MMA, and
approximately a quarter is excreted as inorganic (Stea 2014; Vahter 2000).
Drinking water levels of As correlate well with nail and urine As concentrations
(Chen et al. 2013, Karim et all. 2013, WHO 2011). As has an affinity for thiolcontaining molecules (Hughes et al. 2011; Schmidt et al. 2009) and is known to
bind plasma proteins including the antioxidants glutathione and thioredoxin. In
rats exposed to As (III) in food for 42 days, DMA(V) was the predominant form of
As found in both plasma and bound to erythrocytes at doses as low as 1 parts
per million (ppm), whereas As (III) was found in plasma only at the highest
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exposure dose (100 ppm) (Chen et al. 2013). Rodents are more sensitive to As
thus making translations to humans is uncertain.

Nickel
Other metal contaminants found in drinking water and presumably in soils and air
on the Navajo Nation include Ni, V, and Cu. Most Ni is absorbed through the gut.
About 5% of the absorbed Ni moves from the intestines into the bloodstream,
and approximately 20-35% of inhaled Ni is absorbed through the lungs. Most of
the Ni that reaches the blood is rapidly excreted in urine. Much of the remaining
Ni is evenly distributed throughout the body. The biological half-life of Ni is more
than 3 years. (ANL 2005)

Vanadium
Vanadium also exists in many oxidation states making it a particularly complex
metal in the human body (Mukherjee et al. 2004). The toxicity of V generally
increases as the valence state increases, with the eyes and lung be most
affected (Barceloux 1999). Diet is the main source of V, and most ingested V is
not absorbed; V that is absorbed is rapidly transported by proteins to various
tissues. Most V in the blood is bound to albumin and transferrin. Vanadium has
been found to inhibit many enzymes. Vanadium may be incorporated into many
various organs and tissues including bone, liver, kidney, brain, muscles and heart
(Mukherjee et al. 2004). Little to no toxicity has been shown after long-term
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supplementation of V compounds. Vanadium compounds may affect glucose
(Srivastava and Mehdi 2005) and lipid metabolism (Zhang et al. 2014)

Copper
Copper, which is primarily obtained from the diet, rapidly appears in the
bloodstream and is taken up mainly by the liver (Gaetke and Chow 2003).
Women generally have higher levels of Cu than men (Milne 1998). The majority
of Cu is bound to ceruloplasmin, the most abundant of many Cu -binding
proteins, while much of the remainder is contained within several enzymes
including superoxide dismutase and cytochrome c oxidase (Milne 1998). Copper
is an essential nutrient and a common cofactor that is generally maintained at
normal levels due to strong homeostatic control mechanisms (Gaetke and Chow
2003; Milne 1998). Deficiency is more common than toxicity, and low or high
levels of Cu can be detrimental, including to the vasculature (Ford 2000;
Schuschke et al. 1997). The main mechanism by which damage occurs is
thought to be through Cu-induced oxidative stress; Cu is also known to
oxidatively modify LDL cholesterol (Gaetke and Chow 2003).
Metals exposures and CVD
The Southwestern U.S. has disproportionately higher levels of As in drinking
water where many Native Americans reside. The communities of the Navajo
Nation, located in the four-corners region of the southwestern United States,
have exposure risks from a legacy of AUMs (USEPA 2008, 2013; deLemos
2009). While lifestyle, socioeconomic challenges and genetic factors play a
16

significant role in the development of CV-heath conditions. Remaining U
deposits along with other co-occurring metals including As, lead, V, Ni, and Cu
may contribute to CV health effects. Environmental exposures to toxic metals
have been associated with CVD and diabetes.

Epidemiology: Arsenic and CVD
Numerous epidemiological studies have linked groundwater contamination to
adverse CV health effects. High As levels in drinking water are associated with
increased the risk of coronary heart disease, peripheral artery disease, stroke,
and carotid atherosclerosis in studies worldwide. In the 1990s, Bangladesh was
the site of large-scale As exposure in which thousands of residents were
exposed via drinking water. Many other regions have significant As exposures,
which have manifested as peripheral artery disease (also known as Blackfoot
disease) implicated the vasculature as a target of As toxicity (Tseng 2002). A
follow-up study in Taiwan assessed the interaction between As exposure and
urinary As speciation on the risk of peripheral artery disease (Tseng et al. 2005).
This study found that aging was associated with a decreased ability to methylate
inorganic As and that women were better able to methylate As than men. In
addition, peripheral artery disease risk increased with a higher cumulative As
exposure and a lower capacity to methylate As (Tseng et al. 2005). Another
study in Bangladesh found a dose-response relationship
between exposure to As in well water assessed at baseline and mortality from
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ischemic heart disease and other heart disease, with hazard ratios increasing
with greater quartiles of As drinking water concentration (Chen Y et al. 2011).

The majority of studies, both epidemiological and mechanistic, have focused on
high As concentrations, and more studies are needed to assess the relationship
between low to moderate As exposure and CVD. Meliker et al (2007) examined
mortality in a U.S. population with <100 μg/L water As concentrations and found
increased mortality rates for all cardio- and cerebrovascular diseases, diabetes
and kidney diseases. Another study conducted in Spain found higher mortality
rates for cardiovascular, coronary, and cerebrovascular disease in a population
with drinking water concentrations >10 μg/L versus those with concentrations <1
μg/L (Medrano et al. 2007).

Low to moderate As exposure may be a cardiovascular risk factor with no
apparent threshold (Schmidt et al. 2014). EPA maximum contaminant level of 10
parts per billion (ppb) in drinking water was established based on risk of
developing kidney cancer, but the cardiovascular system may be sensitive to
lower concentrations. Most study designs have been ecological and there is a
need to examine As exposure at the individual level. (Moon et al. 2012; NavasAcien et al. 2005)

In populations from the SHS, urine levels that indicated low to moderate
inorganic As exposure, were prospectively associated CVD and CVD mortality,
and these associations remained after adjustment for socio-demographic factors,
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lipids, and smoking. The findings were attenuated with further adjustment for
hypertension, diabetes, and measures of kidney disease, which the authors
suggest may variables in the causal pathway (Moon et al. 2013). Several studies
from the As-endemic regions of Taiwan and Bangladesh have found links
between As exposure and vascular inflammation and endothelial dysfunction. In
the Health Effects of As Longitudinal Study, urinary As and well-water As were
positively associated with plasma levels of soluble VCAM-1 (sVCAM-1). They
also found that associations between As exposure and increased levels of
plasminogen activator inhibitor-1 and soluble VCAM-1 were stronger among
people with higher body mass index (BMI) (Wu 2012). Another study in
Bangladesh found that well-water As was positively associated with both ICAM-1
and VCAM-1 and with changes in these two markers over time (Chen et al.
2007). More recently, Karim et al. (2013) found that OxLDL, HDL, and CRP
showed dose-response relationships with As exposure. Ox-LDL/HDL ratios were
also increased with the increasing concentrations of As in the water, nails and
hair.

Microarray data of peripheral blood mononuclear cell from 24 individuals
exposed to intermediate- to high-levels of As in Taiwan suggest that a number of
pro-inflammatory genes are upregulated, including IL6, CCL2, and interleukin-1β.
Multivariate analysis of 64 exposed individuals from the same study showed that
the association of plasma CCL2 levels with blood As remained significant after
adjustment for other CVD risk factors (Wu et al. 2003), but other results have
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been inconsistent which may indicate possible influences due to ethnic and/or
environmental conditions (Salgado-Bustamante et al. 2010).

Toxicology: Arsenic and CVD
Several mechanistic studies have found links between As exposure and
manifestations of CVD. In apolipoprotien E deficient (ApoE-/-) mice that were
exposed to 20 or 100 μg/mL sodium arsenite (NaAsO2) in drinking water for 24
weeks, lesions of the aorta were increased significantly compared with nontreated control mice (Simeonova et al. 2003). They also found an accumulation
of As in the vessel wall without changes in serum cholesterol. Mice also ate
cocoa butter in their diet for 2 weeks, which resulted in higher serum cholesterol
levels and only slight increases in lesion size in both control and As-exposed
ApoE-/- mice. In the same study, As treatment of endothelial cells induced the
expression of inflammatory mediators, including interleukin-8 (Simeonova et al.
2003). When Srivastava et al. (2009) exposed ApoE-/- mice to a high level (49
ppm) of As for 24 weeks, they found increased lesion formation by 2- to 3.6-fold
in the aortic valve, the aortic arch and the abdominal aorta. Lesions also showed
an increase in macrophage accumulation as well as pro-inflammatory molecules,
such as CCL2, IL6, protein-hydroxynonenal and protein-malondialdehyde (MDA)adducts, in As-exposed mice. Plasma concentrations of CCL2, IL6 and MDA
were also significantly elevated in As-exposed mice. Lemaire et al. (2011) did
similar studies in ApoE-/- mice with lower As concentrations (200 ppb) and again
found increased atherosclerotic lesions compared to controls. When they tried
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high and low concentrations, interestingly, the lower exposure concentration (200
ppb) was more atherogenic than the higher concentration (1000 ppb). Asenhanced lesions were also associated with increased proinflammatory cytokines
and decreased LXR target gene expression, which is involved in cholesterol
regulation (Lemaire et al. 2011).

Although still not well understood, several modes of action of As toxicity have
been proposed including: interactions with sulfhydryl groups on proteins and
enzymes, alteration of cellular signal transduction, arsenate substitution of
phosphate (since both share physiochemical properties), substitution for zinc in
zinc finger binding domains, and genotoxic effects (Flora 2011; Hughes et al.
2011). Other indirect processes via the formation of ROS (Barchowsky et al.
1996) could also contribute to the pathogenic mechanism for the CV effects of
As. (Stea et al. 2014) Modification of cysteines, especially dithiols, on a number
of molecules by As may affect redox status. Some studies have suggested that
NFκB, a major transcription factor that regulates inflammatory processes, can be
induced in arsenite-exposed macrophages and endothelial cells through
oxidative stress. (Barchowsky et al. 1996; Hossain et al. 2013). Inflammatory
cytokines may be induced in the liver due to the metabolism of As or hepatic
injury.

Epidemiology: Uranium and CVD
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Few epidemiology studies have looked at chronic, low-dose exposure to U,
especially in CVD. A dose-response relationship has been identified between U
exposure has been associated with both diastolic and systolic blood pressures
(DBP, SBP, respectively); cumulative U intake has been associated with
increased urinary excretion of glucose but these effects may be secondary to
kidney toxicity (Kurttio et al. 2006). Most of U’s effects are nephrotoxic. Kidney
disease can be a comorbidity of CVD and T2D. U has also been associated with
neurological and reproductive health effects (Brugge and Buchner 2011).

Toxicology: Uranium and Inflammation/Oxidative Stress
Few animal or cell studies have looked at the CVD associated with U exposure.
The following animal studies with U looked at processes related to CVD:
inflammation and oxidative stress. One study examined if chronic ingestion of
depleted U (40 mg/L) for 3, 6, or 9 months would lead to inflammatory changes in
the intestine and found varied responses. Messenger RNA was increased for
interleukin-1β and interleukin-10 at 6 months, and decreased for CCL-2, and this
was associated with decreased macrophage density. Neutrophils were
increased number was observed at 3 (31.7) and 9 months (33). They also
observed decreased endothelial NO synthase messenger RNA at 6 months.
Another study examined the free radical scavenging activity of a carbohydrate
polymer (a potential drug candidate for treatment of depleted U toxicity) on
oxidative stress induced by depleted U (uranyl acetate, UA) in isolated rat
hepatocytes. Rats treated with 50μM but there were no other details provided.
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They found increased ROS formation in isolated hepatocytes, as well as
glutathione depletion, mitochondrial membrane potential collapse and lysosomal
membrane rupture before hepatocyte lysis occurred, which were prevented by
the carbohydrate polymer (Pourahmad et al, 2010). Briner et al (2005) looked at
short- and long-term behavioral effects and lipid oxidation in brains from rats
exposed to UA exposure (0, 75, or 150 mg/L in drinking water, equivalent to 0.18
mM and 0.35 mM, respectively) for either 2 weeks or 6 months. Behavioral
differences were seen in male rats after short-term exposure and in female rats
after long-term exposure. Increased brain lipid oxidation was seen for the highest
dose group for both genders and they correlated significantly with the behavioral
measures suggesting that UA can cross the blood brain barrier in these rats.

Other Metals Associated with CVD
Cadmium, mercury, lead and Cu are also suspected to be clinically and
mechanistically associated with various measures of CVD (Jomova and Valko
2011; Solenkova 2014). Cadmium exposure has been associated with
atherosclerosis development in the hypercholesterolemic rabbit (Subramanyam
et al. 1992), increased carotid intima-media thickness in young healthy women
(Messner et al., 2009), and with peripheral artery disease as measured by ankle
brachial index, in participants from the SHS (Tellez-Plaza 2013). In a prospective
4-year follow-up study in a population-based sample of men from Finland,
baseline hair mercury content was the strongest predictor of increased mean
intima-media thickness as determined by ultrasonographic assessment, after
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adjusting for other atherosclerotic risk factors (Salonen et al. 2000). Numerous
studies have shown an association between lead exposure and hypertension and
several clinical cardiovascular outcomes and mortality (Navas-Acien et al. 2007).
Copper, a redox active metal, is also associated with CVD, atherosclerosis, CVD
mortality, and LDL oxidation (Jomova and Valko 2011). Many effects of Cu can
be attributed to the induction of oxidative stress either by the formation of ROS
via a Fenton-like reaction and by decreasing glutathione levels. Copper is known
to oxidize LDL in vitro (as well as HDL), and can interact with another CVD risk
factor, homocysteine, to oxidize LDL (Burkitt 2001; Jamova and Valko 2011).

Role of Metals in Lipid Oxidation
LDL may be oxidized by reactive oxygen or nitrogen species, metal ions, and
enzymes secreted by immune cells such as myeloperoxidase (Yoshida et al. and
Kisugi 2010). Copper sulfate (CuSO4) is commonly used to induce oxidation of
LDL (Burkitt 2001). The oxidation of LDL by Cu in vitro may occur differently
from the process occurring in vivo, but metal ions, including Cu as well as iron,
have been shown to be required for cell-mediated LDL oxidation. In vitro, it is
believed that Cu binds to histidine residues within the ApoB-100 protein of the
LDL particle where it may cause lipid oxidation through a variety of reactions,
which may or may not involve a reducing agent (Burkitt 2001; Wagner and
Heinecke 1997). Several studies have found associations between metals
exposures and carotid atherosclerosis (Lind et al. 2012) and lipid oxidation (Ani
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et al. 2007; Elis et al. 2001; Kapiotis et al. 2002). However, it is unknown if As or
U can lead to LDL/lipid oxidation.
Metals exposures and changes in serum composition
Increased levels of reactive oxidants and decreased antioxidant capacity have
been found in plasma from humans exposed to As in drinking water Wu et al.
2001). Many metals can inactivate or alter proteins due to an affinity for
sulfhydryl groups, which is significant since proteins in the plasma may account
for up to 50% of the anti-oxidative capacity of plasma. In addition, inflammation
can increase binding of modified-LDL to endothelium and smooth muscle (Ross
1999).

We have previously shown that inflammatory potential, as measured by
endothelial cell responses to serum derived from humans exposed to diesel
exhaust, was exhibited by increases in ICAM-1 and VCAM-1 messenger
ribonucleic acid (mRNA) (Channell et al. 2012). It has also been shown that
when human umbilical vein endothelial cells and/or THP-1 monocytes were
exposed to metal-based nanomaterials, there were increased gene expression
levels of heme-oxygenase-1 and interleukin-8, ICAM-1, and VCAM-1, as well as
increased adhesion of THP-1 monocytic cells onto endothelial cells (Danielsen et
al. 2015). It is plausible that exposure to metal-mining contaminants could lead
to changes in the circulation in Navajo residents, including increases in LDL
oxidation and serum inflammatory potential.
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Rationale for Research
Numerous AUMs within the Navajo Nation have left behind a mixture of metals
including U and As in water, soil, and likely air. The Navajo are an underserved
population that in recent decades have seen high prevalence rates of obesity and
overweight, hypertension, and diabetes, which historically have been lower in
Native Americans than in the general population. Rates of coronary artery
disease and metabolic syndrome are also on the rise. We hypothesize that
endothelial activation and inflammation in the circulatory system, which are
involved in the pathophysiology of these CV-related conditions, are exacerbated
by exposures to metals from legacy mining.

The circulation represents the balance of inflammation, i.e. inflammatory
potential, to which the endothelium responds by expressing adhesion molecules
and chemokines, which recruit macrophages to sites of inflammation. Scavenger
receptors on immune and endothelial cells recognize and internalize oxidativelymodified LDL leading to a progressive inflammatory response central to
atherosclerotic plaque formation. Circulating oxidized LDL is an emerging CV
biomarker. Metals exposures are associated with lipid oxidation (Ani et al. 2007;
Elis et al. 2001; Kapiotis et al. 2002). It is unknown if As and U are able to
directly oxidize LDL. Metals exposures may also influence inflammatory changes
in the circulation. The circulation contains the balance of pro- and antiinflammatory mediators, i.e. inflammatory potential, which we have assessed
using a novel method in our lab (Cung et al. 2015, Channell et al. 2012), but this
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novel method has not been applied at the community level. Because the major
cause of non-accidental mortality in Navajo, as well as worldwide, is due to CVD,
even a slight increase in risk, such as due to exposure to toxic metals, may
indicate a large quantity of excess mortality (Moon et al. 2013).

Central Hypothesis: Exposures to AUM contaminants are associated with proatherogenic changes in the circulation.

AIM 1: Characterize oxLDL and its relationship to CVD and T2D risk factors in a
subset of the DiNEH participants.
Rationale: OxLDL is a novel CVD biomarker that is predictive of acute MI and
subclinical atherosclerosis (Meisinger et al. 2005; Wallenfeldt et al. 2004) and is
associated with other CV-related outcomes including metabolic
syndrome/diabetes (Holvoet et al. 2004; Hussein et al. 2007). However, oxLDL
and its relationship to CVD and type 2 diabetes risk factors have never been
characterized in the Navajo population. To assess this, we obtained survey
health information and laboratory assessments from a subset of volunteers from
the DiNEH study and measured plasma oxLDL by an enzyme linked
immunosorbent assay (ELISA). Pearson correlations and linear regression were
used to evaluate associations between oxLDL and CVD and type 2 diabetes risk
factors.
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AIM 2: Determine the association between drinking water intake of U and As
and oxLDL in a subset of the DiNEH participants, and determine the extent to
which these metals directly oxidize LDL.
Rationale: Navajo have expressed the need for epidemiological studies
investigating health concerns potentially due to U mining contamination (USEPA
2008). As and U are the major metal contaminates of drinking water on the
Navajo Nation. Chronic As is associated with CVD, but few studies have
assessed the association of U with CVD. This population has an increasing
prevalence of CV-related health conditions. OxLDL is a novel biomarker of CVD
and CVD risk. Metals exposures have been associated with oxLDL as a
biomarker (Karim et al. 2013), carotid atherosclerosis (Lind et al 2012) and lipid
oxidation (Ani et al. 2007). We tested the hypothesis that As and U intake from
drinking water would be associated with oxLDL in the DiNEH subset, and that
these metals would directly oxidize LDL in an acellular system, as proof-ofconcept. We developed linear regression models to evaluate the relationship
between participant oxLDL levels and drinking water intakes of As and U and
potential covariates. To test if As and U could oxidized LDL, we designed an
acellular assay in which purified human LDL was incubated with varying
concentrations of the same metals and measured oxLDL by ELISA and lipid
peroxidation by the thiobarbituric acid reactive substances (TBARS) assay.
AIM 3: To determine the contribution of AUM exposures to community-level
serum inflammatory potential
Rationale:
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Residents living in close proximity to AUMs have a near doubling of risk for
hypertension as compared to those living further away (Hund et al. 2015).
Chronic exposures to a mixture of mining contaminants may occur through
multiple pathways (drinking water, inhalation). Increased free radical production
and inflammatory factors may be induced by the presence of toxic metals in
plasma or atherosclerotic lesions (Shi et al. 2004). Inflammatory changes in the
circulation that reflect chronic environmental exposure may be useful in
assessing health effects of mining waste exposures, such as that experienced by
Navajo Nation communities. We hypothesized that exposure to mining waste
contaminants, in terms of drinking water intake and AUM proximity, would be
associated with serum inflammatory potential of naïve cultured endothelial cells
treated with serum from the Navajo volunteers. To test this hypothesis, we
applied our novel inflammatory potential assay using serum obtained from
DiNEH volunteers. We then developed linear regression models to then test if
AUM exposures could predict these inflammatory responses.
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II. CHAPTER 2
Associations of Circulating Oxidized LDL and Conventional Biomarkers of
Cardiovascular Disease in a Cross-sectional Study of the Navajo
Population
In press (PLOS ONE)
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ABSTRACT
The prevalence rates of CVD and T2D have increased among the Navajo Native
American community in recent decades. OxLDL is a novel CVD biomarker that
that has never been assessed in the Navajo population. We examined the
relationship of oxLDL to conventional CVD and T2D risk factors and biomarkers
in a cross-sectional population of Navajo participants. This cross-sectional study
included 252 participants from 20 Navajo communities from the DiNEH Project.
Plasma samples were tested for oxLDL levels by a sandwich enzyme-linked
immunosorbent assay. Univariate and multivariate analyses were used to
determine the relationship of oxLDL and oxidized- to non-oxidized lipoprotein
ratios to glycated hemoglobin (HbA1c), CRP, IL6 and demographic and health
variables. Type 2 diabetes, hypertension and obesity are very prevalent in this
Navajo population. HbA1c, CRP, body mass index (BMI), high-density
lipoprotein, and TG were at levels that may increase risk for CVD and T2D.
Median oxLDL level was 47 (36.8-57) U/L. Correlational analysis showed that
although oxLDL alone was not associated with HbA1c, oxLDL/HDL, oxLDL/LDL
and CRP were significantly associated with HbA1c and glucose. OxLDL,
oxLDL/HDL and oxLDL/LDL were significantly associated with CRP. Multivariate
analysis showed that TG were a common and strong predictor of oxLDL,
oxLDL/HDL and oxLDL/LDL. OxLDL was trended with HbA1c and glucose but
did not reach significance, however, HbA1c was an independent predictor of
OxLDL/HDL. CRP trended with oxLDL/HDL and was a weak predictor of
oxLDL/LDL. This Navajo subset appears to have oxLDL levels comparable to
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subjects without evidence of CVD reported in other studies. The high prevalence
of T2D, hypertension and obesity along with abnormal levels of other biomarkers
including HbA1c indicate that the Navajo population has a worsening CVD risk
profile.
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Introduction
Cardiovascular diseases and T2D were rarely reported in the Navajo population
until the 1930s (Salsbury 1937). In recent decades, the prevalence of
cardiovascular related health conditions such as T2D, overweight and
hypertension has increased (CDC 2014; Percy et al. 1997; Mendlein et al. 1997;
Will et al. 1997; Hoy et al. 1995; Howard et al. 1999), with CVD currently being
the leading cause of non-accidental death among Navajos (Percy et al. 1997;
Hoy et al. 1995), as well as in other Native American populations [Howard et al
1999; Rhoades et al. 2005). It has been well-established that diabetes increases
the risk for CVD, and Navajo are now developing T2D at a rate four times higher
than the United States average (Will et al. 1997). In 1997, the last published
comprehensive look at Navajo-specific health status, the Navajo Health and
Nutrition Survey, reported that nearly 40% of Navajos over the age of 45 had
T2D (Will et al. 1997). According to a recent Center for Disease Control report,
the incidence of newly diagnosed T2D among American Indian/Alaskan native
youth aged 10-19 is higher than any other racial/ethnic group in the United States
(U.S.) (CDC 2014). T2D, along with obesity and hypertension, have become
major public health concerns in a population that has become increasingly at risk
for CVD.
Clinically, numerous circulating biomarkers including CRP and IL6 have been
useful in predicting CVD outcomes and assessing risk (Ridker et al. 2009; Pepys
et al. 2003). CRP has long been established as a marker of chronic systemic
inflammation and is regulated by IL6, a pro-inflammatory cytokine and important
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inducer and regulator of chronic inflammation (Yudkin et al. 2000; Gabay et al.
2006). Novel biomarkers for CVD are emerging including oxidized LDL (oxLDL)
cholesterol. OxLDL is increased in subclinical atherosclerosis (Wallenfeldt et al.
2004) and is often a stronger predictor of acute CAD than standard lipid
measures or other conventional risk factors (Meisinger et al. 2005). OxLDL
levels are reportedly able to distinguish patients with CAD from healthy cohorts
(Huang et al. 2008), and serve as a predictor of future myocardial infarction in
patients with unstable CAD (Johnston et al. 2006). Oxidized LDL is also
associated with T2D (Njajou et al. 2009). More research is needed to establish
oxLDL as a clinically useful biomarker.
The relationship between oxLDL and CVD risk factors and biomarkers in the
Navajo community is unknown. Given the high prevalence of T2D in this
population, our purpose was to characterize CVD biomarkers in a cross-sectional
Navajo population and to evaluate the association of oxLDL with HbA1C, widely
accepted as a major biomarker of glycemic control, ultimately to better
understand how these metrics currently trend in an understudied ethnic group.
METHODS
Study Population and Survey Methods
The geographic study area for the study population was located in the
northwestern region of New Mexico, in the political division of the Navajo Nation
known as the Eastern Agency. Demographic and health data were obtained
from the interviewer-administered Water and Land Use, Environmental and
Health Survey, designed by the DiNEH Project (de Lemos et al 2009; 2007)
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which implemented a community-based participatory approach to enroll 1,304
participants from 20 Chapters of the Navajo Nation between 2005 and 2010.
The DiNEH Project was initiated to evaluate kidney disease in the Navajo due to
potential exposures to U from numerous abandoned U mines., The study was
later expanded to evaluate the overall health of this population, including
cardiovascular, immunological and neoplastic diseases. Height and weight were
measured at the time of survey administration to determine BMI. From these
DiNEH participants, we had a recruitment goal for a follow-up blood collection of
450 participants; we had a 40-90% recruitment success rate on any given day
from 2010-2011 for a final total of 252 Navajo participants. Non-fasting plasma
samples were collected along with clinical assessments conducted by a Navajo
Area Indian Health Service mobile unit at multiple community locations. All serum
biomarker data were derived from this subset. Blood pressure was measured by
automatic cuff. All participants provided written informed consent, and the study
was approved by both the University of New Mexico Human Research Review
Committee and the Navajo Nation Human Research Review Board.
Biomarker Measurements
Plasma samples were tested for oxLDL by a sandwich enzyme-linked
immunosorbent assay, according to manufacturer’s instructions (Mercodia,
Uppsala, Sweden) (n = 252). The full volume of intended blood samples was not
available for all participants so subsequent analyses were prioritized resulting in
the N noted below for each of the markers reported herein. IL6 was determined
by MILLIPLEX ultrasensitive human magnetic bead set (Millipore Inc; Billerica,
35

MA) and multiplexing technology to obtain serum cytokine concentration
measures (in pg/ml) (n = 236). Magnetic bead detection was carried out on a
MAGPIX machine and multiplexing platform capable of performing quantitative
analysis of low concentration of protein markers (Luminex Corporation, Austin,
TX). Analytical values were determined by xPONENT 4.2 Software (Luminex
Corporation, Austin, TX) by standards provided in the assay kit for each
cytokine. All remaining biochemical analyses were performed by a reference
laboratory (LabCorp, Phoenix, AZ), reported to Indian Health Services and
compiled in a clinical database (RedCAP). HbA1c (n = 249) was determined by
the Roche Tina-quant assay. CRP (n = 249) was assessed quantitatively by latex
immunoturbidimetry. There were 217 samples available for assessing total
serum cholesterol, HDL, and TG, which were measured by conventional clinical
analytical methods; LDL was measured directly (n = 211).
Statistical Analysis
Descriptive summary statistics were reported as median and interquartile range
(IQR) for continuous variables, unless otherwise indicated. Non-Gaussian
distributions were normalized using a logarithmic transformation. Pearson
correlations and multivariate analysis were performed to assess the relationship
of oxLDL to other CVD and T2D risk factors and biomarkers. A value of P < 0.05
was considered statistically significant. Statistical analyses were performed
using R version 2.12.1 (The R Foundation for Statistical Computing, 2010, 64-bit)
and GraphPad Prism 6.0 (GraphPad Software, La Jolla, CA, USA). All
multivariate models were adjusted for age, gender, BMI, total cholesterol (TC),
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TG, diastolic and systolic blood pressures, non-fasting glucose, HbA1c, CRP,
and IL6. The model for oxLDL/HDL was also adjusted for LDL cholesterol, and
the oxLDL/LDL model was adjusted for HDL cholesterol. Model selection was
performed based on Akaike Information Criterion (AIC) or Bayesian Information
Criterion.

RESULTS
Clinical Characteristics and Prevalence of Health Conditions in the Navajo
Population
Table 2.1 shows the characteristics of the Navajo population subset (n = 252)
relative to the original DiNEH study mean age of 55.3 ±14.3 years versus 51.5
±17.4 years, respectively; both were similar in gender proportion, BMI and selfreported health conditions. Diabetes and hypertension were the predominant
conditions self-reported by both the subset and original DiNEH population, at
26.2% (subset) and 25.1% (DiNEH) for diabetes and 38.1% (subset) and 35.9%
(DiNEH) for hypertension; heart disease, stroke and myocardial infarction were
less prevalent in both groups.
The prevalence of obesity (BMI ≥30 kg/m²) in the Navajo subset was 47.6%,
which was higher than the prevalence in the original DiNEH study population
(41.2%) (Table 2.1). Over one-third of both study populations were overweight
(BMI 25.0-29.9 kg/m²). Furthermore, the majority of participants in both the
subset (84.7%) and original DiNEH population (76.2%) had BMI values
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considered either “overweight” or “obese.” Only 23% of original DiNEH
participants and 14.5% of the subset were within a normal BMI range (18.5-24.9
kg/m²).

Median systolic blood pressure in the Navajo subset was pre-hypertensive; for
68% of this study population, systolic pressures were at or above prehypertensive levels (>120 mmHg) according to American Heart Association
guidelines (Chobanian et al. 2003) (Table 2.1). Median diastolic blood pressure
was normal although almost half (47%) of the subset had diastolic pressures that
were measured at or above pre-hypertensive levels (>80 mmHg). Blood
pressure measurements were not available for the original DiNEH population.
Thirty-five percent of the subset reported taking hypertension medication.

Levels of Biomarkers Associated with CVD and T2D
Plasma biomarker levels for the Navajo subset are shown in Table 2.1. The
median oxLDL level in the Navajo subset was 46.9 (36.8-57) U/L. The median
IL6 level was 5.9 (1.8-12.5) pg/ml. Currently, reference ranges for oxLDL and
IL6 as biomarkers have not been established. The median CRP level was 2.1
(0.9-4.8) mg/L (average risk), however, 38.5% had levels greater than 3.0 mg/L,
which is considered high risk for heart disease (Pearson et al. 2003). Circulating
lipid levels are shown in Table 2.1. Based on American Heart Association
guidelines (National Cholesterol Education Program 2002), median TC in this
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Table 2.1 Characteristics and clinical parameters of the Navajo subset and
original DiNEH participants.

Variable

DiNEH Subset
n

DiNEH
Participants*
(n = 1304)

Age, years

55.3 ± 14.3

252

51.5 ± 17.4

Female, %

57.5

252

56.4

Self-reported health conditions

252

Type 2 Diabetes, %

26.2

25.1

Hypertension, %

38.1

35.9

Heart Disease, %

6

5.4

Myocardial Infarction, %

4.4

3.1

Stroke, %

5.2

Underweight (BMI ≤ 18.4), %

0.8

3.5
28.3 (25.132.6)
0.7

Normal (BMI = 18.5-24.9), %

14.5

23

Overweight (BMI = 25.0-29.9), %

37.1
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Body mass index (BMI), kg/m²

29.7 (26.8–33.6)

252

Obese (BMI ≥ 30), %

47.6

Total Cholesterol, mg/dL

182 (162–204)

217

LDL, mg/dL

105 (90–123)

211

HDL, mg/dL

45 (38–54)

217

TG, mg/dL

41.2

183 (127–251)

217

Systolic BP (mmHg)

129.5 (117-143)

248

Diastolic BP (mmHg)

78 (71–86)

248

2.1 (0.9–4.8)

249

CRP, mg/L
CRP > 3.0 mg/L, %

38.5

oxLDL, U/L

46.9 (36.8–57)

252

IL6, pg/ml

5.9 (1.8-12.5)

236

Glucose (non-fasting), mg/dL

91 (78–121)

249

HbA1c, %

6.2 (5.8–7.1)

249

% Normal (≤ 5.6%)

15.7

% Pre-diabetes (5.7-6.4%)

45.8

% Diabetes (≥ 6.5%)

38.6

*Biomarker levels and blood pressure were not available for the DiNEH participants. Data are
presented as median (IQR) or %. LDL, low-density lipoprotein; HDL, high-density lipoprotein; BP,
blood pressure; HbA1c, glycated hemoglobin; CRP, C-reactive protein; oxLDL, oxidized lowdensity lipoprotein; IL6, interleukin 6.
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subset was “desirable,” and LDL cholesterol levels were near optimal. However,
HDL cholesterol was bordering on low, and TG were high; both are risk factors
for heart disease. No data were available for the use of lipid-lowering
medications in this subset.
As mentioned, a diagnosis of T2D was self-reported by 26.2% of the Navajo
subset (Table 2.1), however, our data indicate that 84% of HbA1c levels in the
Navajo subset as a whole were pre-diabetic (5.7-6.4%) or higher (Table 2.1,
Figure 2.1), as classified by the American Diabetes Association (2012). Indeed,
the median HbA1c in the Navajo subset was pre-diabetic at 6.2% (5.8-7.1%).
Furthermore, as shown in Figure 2.1, of those who denied a diagnosis of
diabetes at the time of survey administration, 59% had pre-diabetic levels of
HbA1c with a mean of 6.3% ± 1.3. HbA1c levels greater than 6.5% are indicative
of diabetes. For participants self-reporting a diagnosis of diabetes, 89% were in
the diabetic range with a mean HbA1c of 8.9% ± 2.5. As a whole, more than a
third (39%) of the subset had diabetic levels of HbA1c, and nearly half (46%)
were in the pre-diabetic range (Table 2.1). Only 16% were in the normal HbA1c
range (<5.6%). The median non-fasting glucose of this Navajo subset was 91
(78-121) mg/dl (Table 2.1), which is comparable to a normal fasting glucose
level. Twenty-five percent of the subset reported taking oral medication and/or
insulin for diabetes.
Oxidized LDL Interactions

40

Table 2.2 Univariate relationships between novel CVD biomarkers with conventional biomarkers and self-reported health
conditions
Variable

oxLDL

oxLDL/HDL

oxLDL/LDL

CRP

IL6

HbA1C

r

p

r

p

r

p

r

p

r

p

r

p

Age (years)

-0.07

0.268

-0.135

0.046

-0.065

0.35

-0.208

0.001

0.018

0.773

Gender

0.02

0.756

-0.111

0.104

-0.001

0.986

-0.005

0.934

0.947

0.058

0.392

0.036

0.602

0.315
<0.0001

0.1
0.021

0.004

0.064
0.235

0.104
0.146

0.115

0.067

0.157

0.013
<0.0001

BMI

(kg/m2)

0.109
0.141

0.116
0.04

-0.026

0.679

0.064

0.314

0.294

-0.006

0.92

0.029

0.645

0.06

0.385

0.013

0.836

-0.186

0.666

<0.0001

0.492
<0.0001

0.13
0.032

0.177
<0.0001

-0.434
-0.377

0.096
0.056

0.086
0.596
-0.143
0.031

0.679
0.019

<0.0001

0.006

<0.0001

0.274
0.006

0.024

0.118

0.005
-0.008

-0.125
-0.003

0.412

-0.003

0.037

<0.0001

0.209

<0.0001

0.067

<0.0001

0.16

0.943

-0.028

0.071

0.023

0.652

0.614
0.564

0.137
0.009

0.389
0.7

0.085
0.002

-0.048

0.929

0.964

0.028

0.963

-0.153

0.658

0.16

0.715

…
0.021

0.829

<0.0001

…

…

…

…

…

…

log CRP (mg/L)

…
0.147

0.34
<0.0001

0.904
0.012

-0.145

0.457
0.523

0.03
0.075

0.167

0.014

0.147

0.034

…

…

…

-0.163

0.009

-0.121
0.172

0.076
0.012

-0.076
0.138

0.272
0.047

…
<0.0001

…

log IL6 (pg/ml)

…
0.249

…

…

…

…

0.196

0.002

0.084

0.189

…

…

Hypertension*

-0.03

0.638

0.034

0.616

Heart attack*

0.822
0.044

0.026

0.701

Diabetes*

-0.014
-0.127

TC (mg/dl)

-0.409

<0.0001

-0.035
-0.744

0.603
<0.0001

TG (mg/dl)

0.592

<0.0001

0.363

HDL (mg/dl)

0.095

<0.0001

LDL (mg/dl)

0.165

SBP (mmHg)
DBP (mmHg)
log oxLDL (U/L)

log HbA1C (%)

0.118

0.062

0.163
0.01
0.203
0.003
0.186
0.007
0.209
0.001
0.826
<0.0001
Glucose (mg/dl)
0.027
0.667
*Participant self-reported health conditions; heart disease and stroke did not correlate with any biomarkers. Pearson correlation coefficients (r). P
< 0.05 was considered statistically significant (bold). Non-Gaussian distributions were log transformed. CVD, cardiovascular disease; oxLDL,
oxidized low-density lipoprotein; LDL, low-density lipoprotein; HDL, high-density lipoprotein; HbA1c, glycated hemoglobin; CRP, C-reactive protein;
IL6, interleukin 6, SBP, systolic blood pressure; DBP, diastolic blood pressure; BMI, body mass index
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Figure 2.1 Frequency histogram of self-report diabetes versus actual
HbA1c values. Type 2 diabetes (positive) or no type 2 diabetes (negative).
Dashed lines correspond to HbA1c category cutoffs. Normal: HbA1c ≤ 5.6%;
Pre-diabetes: HbA1c = 5.7-6.4%; Diabetes ≥ 6.5%
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Table 2.2 shows the Pearson correlations of oxLDL and oxidized- to non-oxidized
lipoprotein ratios (oxLDL/HDL and oxLDL/LDL) to more conventional risk factors
and biomarkers of CVD and T2D in this Navajo subset of volunteers. OxLDL
trended positively with HbA1c but did not reach significance. OxLDL was
moderately correlated with non-fasting glucose but negatively correlated with
self-report of diabetes. When oxLDL levels were compared between normal,
pre-diabetic, and diabetic levels of HbA1c, no differences were found; the same
was true for the oxidized-to non-oxidized lipoprotein ratios (data not shown).
Both oxLDL/HDL and oxLDL/LDL were moderately correlated with HbA1c and
non-fasting glucose. CRP, but not IL6, correlated moderately with HbA1c and
non-fasting glucose. HbA1c was strongly correlated with non-fasting glucose
and self-report of diabetes. OxLDL and oxLDL/HDL were strongly correlated with
DBP, and CRP was weakly correlated with DBP, but HbA1c was the only
biomarker associated with a self-report of high blood pressure. OxLDL/LDL was
significantly correlated with self-report of heart attack. OxLDL, oxLDL/HDL, and
oxLDL/LDL correlated significantly with each other and with all conventional lipid
biomarkers, TC, TG, HDL and LDL (with the exception that oxLDL/LDL did not
correlate with TC). HbA1c was weakly correlated with TG and negatively
correlated with HDL. CRP was also negatively correlated with HDL. IL6 was
weakly correlated with TC and negatively correlated with TG. OxLDL,
oxLDL/HDL and oxLDL/LDL were moderately correlated with CRP. OxLDL was
negatively correlated with IL6. CRP was moderately correlated with IL6.
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OxLDL/HDL and CRP were negatively correlated with age. HbA1c and CRP
were moderately correlated BMI. HbA1c was the only biomarker correlated with
gender.

Multivariate analysis
Multivariate analysis confirmed that oxLDL was independently and significantly
associated with TC, LDL and TG but not CRP or IL6. OxLDL was marginally
associated with age, HbA1c and glucose, but these associations did not reach
significance (Table 2.3). TG were a very strong predictor of oxLDL/HDL.
OxLDL/HDL was independently and positively associated with HbA1c but
negatively associated with glucose. OxLDL/HDL was weakly and negatively
associated with age and TC and positively associated with LDL. OxLDL/HDL
trended positively with CRP but did not reach significance. OxLDL/LDL was
independently associated with TG and weakly associated with CRP. OxLDL/LDL
was negatively associated with TC and BMI (Table 2.3).
DISCUSSION
Our goal was to measure oxLDL and examine its relationship to health
characteristics and T2D in a cross-sectional subset of the Navajo Nation, as
oxLDL has never been assessed in this population. The median oxLDL level in
this subset was 47 U/L (IQR: 36.8-57) and ranged from 12.7-138.2 U/L. The
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Table 2.3 Coefficient estimates of final models for oxLDL, oxLDL/HDL and oxLDL/LDL
Variable
Age
Gender
BMI
SBP
DBP
TC
LDL
HDL
TG*
HbA1c
Glucose*†
CRP*
IL6*
n
Adjusted
R2
AIC
BIC

OxLDL
Estimate
Error
-0.112
0.061
-0.71
1.59
-0.23
0.147
0.052
0.051
-0.061
0.082
0.168
0.064
0.14
0.057
-0.317
0.086
6.254
2.963
0.636
0.361
2.75
1.437
0.454
0.669
-1.013
0.809
191

P
0.067
0.656
0.12
0.303
0.456
0.01
0.015
0.0003
0.036
0.08
0.057
0.498
0.212

OxLDL/HDL
Estimate
Error
P
-0.005
0.002
0.009
0.107
0.052
0.041

OxLDL/LDL
Estimate
Error

P

-0.003

0.001

0.046

-0.006
0.01

0.001
0.001

<0.0001
<0.0001

-0.001

0.0002

<0.0001

0.851
0.062
-0.203
0.042

0.059
0.023
0.098
0.022

<0.0001
0.0094
0.039
0.057

0.169

0.016

<0.0001

0.014

0.006

0.028

204

206

0.649

0.638

0.351

1426.084
1471.616

161.012
194.193

-336.174
-316.206

P < 0.05 was considered statistically significant. *Non-Gaussian distributions were log transformed. †Non-fasting.
OxLDL, oxidized low-density lipoprotein; LDL, low-density lipoprotein; HDL, high-density lipoprotein; BMI, body mass
index; SBP, systolic blood pressure; DBP, diastolic blood pressure; TC, total cholesterol; TG, TG; HbA1c, glycated
hemoglobin; CRP, C-reactive protein; IL6, interleukin
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mean oxLDL level (48.5 ± 17.0 U/L) was similar to mean oxLDL levels measured
in subjects without evidence of atherosclerosis reported in other studies
(Supplementary Table 2.1; (Meisinger et al. 2005; Gomez et al. 2014;
Mascarenhas-Melo et al. 2013; Pawlak et al. 2013; Girona et al. 2008) that also
used the same murine monoclonal antibody 4E6 based ELISA (Holvoet et al.
1998). However, oxLDL levels varied widely in these studies and consistent
associations related to CAD or diabetes disease status are difficult to discern.
Increased levels of HbA1c, a biomarker for T2D, have been associated with
CAD, overall CVD, and all-cause mortality (Khaw et al. 2014; Liu et al. 2011).
For the present Navajo subset, the median HbA1c level was in the pre-diabetic
range with the majority of participants having pre-diabetic (46%) or diabetic
(39%) levels of HbA1c. Other studies have shown an association between
oxLDL and HbA1c (Njajou et al. 2009), but in the present study univariate
analysis showed that the oxLDL/HDL and oxLDL/LDL ratios correlated
significantly with HbA1c, while oxLDL itself correlated only weakly with HbA1c
(p=0.062). We examined the ratios of oxLDL/HDL and oxLDL/LDL as previous
reports suggest that these metrics may be more informative than oxLDL alone
(Huang et al. 2012; Johnston et al. 2006; Lankin et al. 2011). In a similar study
of T2DM, oxLDL/HDL and oxLDL/LDL, but not oxLDL alone, were associated
with atherosclerosis, even when adjusting for BMI, gender, age and
hypolipidemic treatment (Girona et al. 2008). LDL derived from diabetics is more
susceptible to oxidation, and this susceptibility is associated with HbA1c levels
(Matsuda et al. 2013; Hussein et al. 2007). The present Navajo subset also
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showed a similar lipid profile as seen in metabolic syndrome/diabetes, wherein
LDL is normal, but HDL is low and TG are high (Howard et al. 2000; Mendlein et
al. 1997; Nesto et al. 2005; Schumacher et al. 2008). Thus, although LDL may
be lower, it may also be more susceptible to oxidation further increasing CVD risk
in this population.
T2D (26%) and hypertension (38%) in the Navajo subset and original DiNEH
population (25% and 36%, respectively) have increased compared to previous
reports (Mendlein et al. 1997; Will et al. 1997) and are notably greater than the
U.S. prevalence (CDC 2014; Go et al. 2014). Overweight and obesity continue
to be very prevalent (at least 76%) in the Navajo population. In the Navajo
subset, BMI was moderately correlated with CRP and HbA1c but not oxLDL or
oxidized- to non-oxidized lipoprotein ratios. OxLDL was correlated with both
CRP and IL6, suggesting a potential role for the contribution of overall
inflammation to the health status of this population. CRP was also correlated
with oxLDL/HDL and oxLDL/LDL. The Navajo subset exhibited moderate CRP
levels (2.1 mg/dl; IQR: 0.9-4.8), but over 38% had levels greater than 3.0 mg/dl
consistent with increasing risk for CVD. Mechanistic studies have demonstrated
that CRP and oxLDL may be interacting in concert to promote atherosclerosis
(Singh et al. 2008; Li et al. 2015). Despite low self-report of heart disease, heart
attack and stroke, these data suggest that CVD- and T2D-related conditions may
become more prevalent in this middle-aged Navajo population.
It is not surprising that standard lipid measures are predictive overall of oxLDL
and oxLDL ratios with HDL and LDL. TG in particular were positively associated
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with all three response-variables, which is consistent with other studies that have
assessed lipid oxidation in diabetes (Verges et al. 2009; Gowri et al. 1999;
Makimattila et al. 1999). HbA1c seems to be somewhat predictive of oxLDL/HDL
and perhaps oxLDL but not oxLDL/LDL. Non-fasting glucose was negatively
associated with oxLDL/HDL but slightly positively associated with oxLDL possibly
reflecting more of a post-prandial response. It has been suggested that LDL
oxidation is associated with dyslipidemia as diabetes progresses (Kopprasch et
al. 2002). Although not measured in this study, small dense LDL particles, HDL
abnormalities and diminished serum anti-oxidative capacity in diabetics are
strongly associated with metabolic syndrome and diabetes (Verges et al. 2009;
Gowri et al. 1999; Makimattila et al. 1999; Brizzi et al. 2003). Inflammation is a
component of both atherogenesis and the development of diabetes. CRP was
somewhat predictive of the oxLDL ratios with HDL and LDL but not of oxLDL
itself. Age was negatively associated with oxLDL and oxLDL/HDL suggesting
that these variables decrease in middle age in the Navajo population.
OxLDL/HDL appears to be higher in women.
Study Limitations
An important limitation of our study was that some plasma obtained for biomarker
assessments (2010-2011) was collected at the end of the survey administration
(2005-2010). Thus, subjects may not have initially reported health conditions for
which they were later diagnosed. Although review of medical records was
attempted, complete records were not available for all volunteers so not all selfreported health conditions could be validated. Navajo also engage in traditional
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medical practices, which would not be included in clinical medical records.
However, for the self-reported measures of BMI (data not shown) and diabetes
where sufficient clinical data were available at the time of blood collection,
concordance with self-report was >80% with errors. Thus, given that the time
between survey and clinical assessment could range as long as 5 years,
observed discrepancies were consistent with a clinical finding of disease
subsequent to the survey. Although bias may present due to self-selection, the
Navajo subset was similar to the larger DiNEH study population based on age,
gender, BMI and self-reported disease conditions. Non-fasting blood samples
may impact some of the biomarker levels, however, non-fasting lipid levels may
better predict risk of cardiovascular events (Langsted et al. 2011). Participant
use of diabetic and hypertensive medications was not included in our initial
analysis.
The cross-sectional nature of this study does not allow for the determination of
causality. The results of this study cannot be generalized to other populations.
Finally, this population is known to have significant environmental exposure risks
to metals from the legacy of U mining. However, the study population reported
herein spans the full range of those exposures, including a significant proportion
of unexposed participants (Hund et al. 2015), improving the generalizability of our
results.
Conclusions
The Navajo population faces a dramatic increase in overall CVD risk profile. This
population is greatly in need of better control of diabetes, hypertension and
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obesity to prevent future CVD-related health complications. Concentrations of
the CVD marker oxLDL in the Navajo population trend with indices of metabolic
syndrome and T2D, but were consistent with several other published cohorts.
The relationship between oxLDL and absolute CVD risk in individuals with prediabetes and diabetes from this underserved ethnic group remains unclear.
Ongoing and future analyses are exploring the potential role of chronic
environmental exposures and other possible socioeconomic and lifestyle risk
factors in contributing to cardiometabolic disease.
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Table 2.1S Comparison of Navajo subset mean oxLDL levels, age, BMI, and HbA1c and/or diabetes status with other
studies using monoclonal antibody 4E6 to measure circulating oxLDL
Population studied
Navajo population
General population
No CAD event
CAD event
No subclinical atherosclerosis
Subclinical atherosclerosis

oxLDL
(U/L)

Age
(yrs)

BMI
(kg/m2)

HbA1c
(%)

Diabetes
(%)

N

Country

Reference

48.5

55

30

7

38.6

252

53.2
65.1
51.8
57.8

49.5
60
45.4
58

27
29.1
26.9
28.3

n/a
n/a
n/a
n/a

11.4
26
7.9
16.7

2690
103
1121
306

U.S.
Spain

Gómez et al. 2014

Patients w/o CVD
Normal HDL
Low HDL
Patients w/ risk factors for CVD
Normal HDL
Low HDL
Subjects w/o ESRD or CVD
ESRD on peritoneal dialysis
ESRD on hemodialysis
Type 2 diabetes
No atherosclerosis
Atherosclerosis

45.7
39.2

57.6
57.9

27
28.8

6
6.3

n/a
n/a

51
22

35.7
40.1
38.3
27.3
30.8

62
60
53.2
52.8
57.7

29.2
29.9
26
25.5
25

8.1
9.4
n/a
n/a
n/a

n/a
n/a
none
25
14.8

119
50
20
52
54

67.4
70.4

60.8
64.9

31
29

7
7

n/a
n/a

93
73

Patients w/o CHD event

93

61.3

27.7

n/a

none

258

Patients w/ CHD event

110

61.1

28.6

n/a

none

88

Portugal

MascarenhasMelo et al. 2013

Poland

Pawlak et al. 2013

Spain

Girona et al. 2008

Multinational;
men only

Meisinger et al.
2005

*Some subjects were taking lipid-lowering medications. oxLDL, oxidized LDL; BMI, body mass index; HbA1c, glycated hemoglobin; LDL, lowdensity lipoprotein; CAD, coronary artery disease; HDL, high-density lipoprotein; CVD, cardiovascular disease; ESRD, end-stage renal disease;
CHD, coronary heart disease. All values are means or percent as indicated, reported by the corresponding study
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III. CHAPTER 3
Arsenic Contribution to Circulating Oxidized LDL in a Native Community
In preparation for submission to Environmental Health Perspectives
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ABSTRACT
More than 500 abandoned U mines within the Navajo Nation contribute U, As
and other metals to groundwater, soil and potentially air through Aeolian
transport. The cardiovascular health effects of cumulative exposure to these
metals remain uncertain. We tested the hypothesis that environmental exposure
to these metals may promote or exacerbate the oxidation of oxLDL cholesterol in
a Native American population. CV biomarker data (oxLDL and CRP) from a
Navajo cohort (N=252) were linked to mean annual As and U intakes from water
and urine metals concentrations using linear regression. Proof-of-concept
assays were performed to investigate whether As and U could directly oxidize
human LDL. Mean annual As intake from water was a robust predictor of oxLDL,
but not CRP in this Navajo group, while U intake estimates were negatively
associated with oxLDL. In an acellular system, As, but not U, directly oxidized
the ApoB 100 component of purified human LDL. As in combination with U may
additively oxidize LDL. Neither metal promoted lipid peroxidation of the LDL
particle. In summary, these findings suggest As intake from drinking water may
influence oxidative modifications of LDL in the Navajo population where ~20% of
unregulated water sources are known to contain As exceeding the US EPA
maximum contaminant level.
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INTRODUCTION
Navajo Nation community members in the southwestern United States have
significant risks for environmental exposure to metals, including As and U, both
from natural deposits and the legacy of U mining (deLemos JL et al. 2009; Hund
et al. 2015), which was extensive from the 1940s until the 1980s (Brugge and
Goble 2002; USEPA 2008). Chronic exposure to several toxic metals (e.g. As,
lead, chromium) is associated with cardiovascular disease (CVD) (Lind et al.
2012; Prozialeck et al. 2008; Solenkova et al. 2014). In recent decades, the
Navajo population has experienced an increased prevalence of metabolic
syndrome (Schumacher et al. 2008) and coronary heart disease (National
Cholesterol Education Program 2002). While diet and lifestyle are important
contributors to this change, the contribution from exposure to metals in mining
waste is unknown.

As often co-exists with U deposits and is present in legacy U mining wastes
(Blake et al. 2015; Katsoyiannis et al. 2007), contributing to contamination of soil
and water. Approximately 15-20% of unregulated water sources throughout the
Navajo Nation produce exceed current U.S. Environmental Protection Agency
(USEPA) maximum contaminant levels (U.S. Army Corps of Engineers 2000).
Navajo Nation EPA has estimated that more than 30% of the Navajo population
lack access to public water supplies and concerns exist about As and U
exposure through consumption of unregulated water.
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Chronic As exposure is associated with ischemic heart disease, hypertension,
atherosclerosis, diabetes and cardiovascular mortality (Medrano et al. 2010;
Navas-Acien et al. 2006; Rahman et al. 1999; Wang et al. 2002; Tseng et al.
2003). Accumulating epidemiological and mechanistic evidence confirms that
the cardiovascular system is sensitive to low-to-moderate levels of As exposure
(James et al. 2015; Moon et al. 2013; Lemaire et al. 2011). In contrast, little is
known about CV-related effects of chronic low-level exposure to U. Limited
evidence suggests a potential relationship between U exposure and circulatory
system disease (Guseva Canu et al. 2012) and increased systolic and diastolic
blood pressures (Kurttio et al. 2006). In addition, exposure to U waste on Navajo
has been linked to an increased likelihood of hypertension (Hund et al. 2015).

OxLDL is an emerging biomarker that is mechanistically associated with CVD
(Gomez et al. 2014; Holvoet et al. 1998; Trpkovic et al. 2014) and predictive of
cardiovascular outcomes such as acute coronary artery disease (Meisinger et al.
2005) and myocardial infarction (Johnston et al. 2006). CRP is a wellestablished conventional biomarker of inflammatory status associated with
increased CVD risk (Danesh et al. 2004). Recently, oxLDL and CRP levels were
reported to be associated with As exposures in Bangladesh (Karim et al. 2013).
Several essential and non-essential metals are known to contribute indirectly to
oxidation of LDL and lipids (Chisolm and Steinberg 2000; Jamova and Valko
2011). It is unknown if As and U can directly oxidize LDL cholesterol.
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Few studies have examined the relationship between chronic low-level As or U
exposure and CVD in an at-risk community such as the Navajo Nation where
CVD and diabetes are significant public health concerns (Moon et al. 2013). We
assessed the potential impact of these metals on plasma levels of oxLDL and
CRP in several Navajo communities located in the southwestern United States
with varied levels of As and U exposures. We hypothesized that environmental
exposure to As and U is associated with increased plasma oxLDL and CRP. We
also performed proof-of-concept acellular assays to investigate whether As and
U directly oxidize LDL cholesterol.

METHODS
Community-Derived Biomarkers and Exposure Assessments
Cohort Recruitment and Demographic Information
Demographic, water use and clinical data were obtained in partnership with the
DiNEH Project (deLemos et al. 2009; Hund et al., 2015) using their Water and
Land Use, Environmental and Health Survey. This interviewer-administered
survey was completed by 1,304 Navajo Nation members between 2005 and
2010. A volunteer subset of this initial cohort of Navajo participants (n = 252)
provided non-fasting blood and urine samples between 2010-2011 at which time
height and weight were also measured to determine BMI. All data for the current
study were derived from this volunteer subset. All participants provided informed
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consent, with oversight and approval from the UNM Human Research Review
Committee and the Navajo Nation Human Research Review Board.
Water Analysis and Human Exposure Assessments
Study participants reported obtaining water from a total of 180 distinct sources,
including 122 unregulated sources such as wells, springs or livestock watering
stations; 42 public water supply sources; and 14 sources that could not be
classified. In order to evaluate metal exposure via drinking water, DiNEH staff
collected water samples for 124 water sources (101 uregulated, 23 regulated)
from 2003 to 2010 following USEPA protocol #2007. USEPA Region 9
laboratories conducted water quality analyses for unregulated sources using
USEPA analysis method 200.8 (Inductively Coupled Plasma Mass Spectroscopy,
ICP-MS). (A small subset of samples was analyzed by the Carlsbad
Environmental Monitoring and Research Center or at Stanford University.)
Navajo Nation EPA provided public water quality data. The compiled information
resulted in As measurements for 113 sources (15 public water sources and 98
unregulated sources) and U measurements for 108 sources (16 public water
sources and 92 unregulated sources).
Water quality information was unavailable for the remaining 167 unregulated
sources identified by participants so these sources were excluded from
subsequent analyses. For public water system sources without chemical data,
(As, n=52 and U, n=48) the source was assumed to be in compliance with Safe
Drinking Water Act regulations for As (< 10 µg/L) and U (< 30 µg/L) (USEPA
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2013). Multiple imputation was used to generate a set of U and As concentration
estimates from a uniform distribution within the bound of 0 and 2 µg/L. This
process was also used to estimate As and U concentrations in store purchased
and bottled water. Although the 2 μg/L value is well below the US EPA maximum
contaminant level for both As and U, the effect of this choice would be to bias
exposure estimates towards the lower end while creating numeric estimates of
consumption.
Annual consumption of As and U was estimated based on participant selfreported water use and the metal concentration for each water source.
Participants indicated how frequently they visited the source (Fi,j) (where i
indicates the participant and j indicates the water source), the typical volume of
hauled water (Vi,j) and the percentage used for cooking or drinking (Pi,j). This
information was used to calculate the annual volume of water each individual
consumed from each water source (W i,j):
𝑊𝑊𝑖𝑖,𝑗𝑗 = 𝐹𝐹𝑖𝑖,𝑗𝑗 × 𝑉𝑉𝑖𝑖,𝑗𝑗 × 𝑃𝑃𝑖𝑖,𝑗𝑗

(1)

An individual annual intake of As or U (mg/year) from drinking water was then
calculated using the associated As or U concentration where C(As) indicates the
As concentration and C(U) indicates the U concentration:
𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝑖𝑖 = ∑𝑗𝑗∈𝑆𝑆(𝑖𝑖)(𝑊𝑊𝑖𝑖,𝑗𝑗 × 𝐶𝐶(𝐴𝐴𝑠𝑠)𝑖𝑖,𝑗𝑗 )

(2)

𝑈𝑈𝑈𝑈𝑈𝑈𝑈𝑈𝑈𝑈𝑈𝑈𝑈𝑈𝑖𝑖 = ∑𝑗𝑗∈𝑆𝑆(𝑖𝑖)(𝑊𝑊𝑖𝑖,𝑗𝑗 × 𝐶𝐶(𝑈𝑈)𝑖𝑖,𝑗𝑗 )

(3)

Once the cumulative annual intake of water As and U from water was determined
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for each participant, the continuous variable was translated to a binary variable:
low or high metal consumption at the threshold of 1.4 mg/ year, because, for
subjects who took all their drinking water from regulated sources, the estimated
intake was always less than 1.4, for both As and U.
Urine Metals Concentrations
Urinary concentrations of V (V 51), Ni (Ni 60), As (AsO 91), and U (U 238) were
available for 188 participants. Urinary Cu (Cu 63) was available for a subset of
participants (n=94). Urine metals were determined by ICP-MS. Detection limits
for U were high and resulted in many non-detects, therefore, available U data
were examined as a binary variable reflecting detect or non-detect as the
threshold.
Serum Biomarker Analysis
Plasma samples were tested for oxLDL by a sandwich ELISA that uses a
monoclonal antibody specific for an epitope (monoclonal antibody 4E6) of the
apolipoprotein B100 portion of the LDL particle, in accordance with
manufacturer’s instructions (Mercodia, Uppsala, Sweden) (N = 252). All other
biochemical analyses were performed by a Navajo Area Indian Health Service
reference laboratory (LabCorp, Phoenix, AZ). CRP was assessed quantitatively
by latex immunoturbidimetry (LabCorp, Phoenix, AZ) (n= 249). Glycated
hemoglobin (HbA1c) (n = 249) was determined by the Roche Tina-quant assay.
Acellular Assays of Metal-induced LDL Oxidation
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Materials
Acellular studies utilized CuSO4 and NaAsO2 (Sigma-Aldrich Co., St. Louis, MO,
USA); UA (Electron Microscopy Sciences, Hatfield, PA, USA); and highly purified
human LDL (Lee Biosolutions, St. Louis, MS, USA).
Determination of Protein and Lipid Oxidation of LDL
Direct apoprotein B oxidation of the metal-treated LDL samples was determined
by ELISA (as above). Lipid peroxidation in the LDL-metal samples was
determined using a TBARS assay kit, which normalized total lipid peroxides to a
malondialdehyde standard (Cayman Chemical Company, Ann Arbor, MI, USA)
per manufacturer’s instructions.
Treatment of LDL by Metals
Direct metal-induced oxidation of human LDL cholesterol was determined by
performing individual dose responses with CuSO4, NaAsO2, and UA with purified
human LDL. CuSO4 was used as a positive control since it is frequently used
experimentally to oxidize LDL (Burkitt 2001). A concentration of 100 mg/dl
human LDL was incubated with CuSO4 (20, 50, 150 and 450 µM for the oxLDL
ELISA; 15, 25, 45 and 75 µM for the TBARS assay), NaAsO2 (0.02, 0.07, 0.2
and 0.7 µM for the oxLDL ELISA; and 0.2, 0.7, 2 and 7 µM for TBARS assay),
UA (0.3, 3, 30 and 300 nM). LDL was co-incubated with combinations of
NaAsO2 and UA (0.02 µM NaAsO2 and 0.3 nM UA, 0.02 µM NaAsO2 and 3 nM
UA, or 0.07 µM NaAsO2 and 0.3 nM UA). CuSO4 and NaAsO2 were dissolved
in phosphate buffered saline (PBS) to achieve desired concentrations. UA was
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first dissolved in water at a concentration of 100 µM and then diluted to 300 nM in
HEPES to obtain desired concentrations. For the experiments that tested the
combined effect of NaAsO2 and UA, 4-(2-hydroxyethyl)-1piperazineethanesulfonic acid (HEPES) was used to dissolve both metals. After
treatment, metal-treated purified human LDL samples were placed in a chamber
with nitrogen flow for 10 minutes to reduce the contribution of atmospheric
oxygen to LDL oxidation. Samples were then sealed and incubated at 37°C for
1-5 hours. EDTA (4 mM) was immediately added to the final samples at each
time point to chelate the reaction. Samples were immediately frozen at -80°C
until further analysis. Lower concentrations of metals tested were physiologically
relevant to normal and/or background levels of each metal in plasma (Ivanenko
et al. 2013; ATSDR 2007; McMillin et al. 2009; Byrne and Benedik, 1991).
Statistical Analyses
We constructed four linear regression models each for oxLDL and log CRP. All
models (1-4, Tables 3 and 4) used demographic (age, gender) and physiological
variables (BMI, HbA1c), and estimated annual water intakes of U and As as
predictors. Models 3 and 4 also included all urinary metals as
predictors. Models 2 and 4 included 2nd order interactions with age and
gender. The majority (> 80%) of HbA1c levels in the participants were in prediabetic or diabetic categories; therefore a binary variable was used (HbA1c
≤6.4% or >6.4%). Estimated annual intakes of As and U from drinking water also
used the binary variables as previously described (Water As bi, Water
U bi). Urinary metals were skewed and thus log transformed except in the case
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of urine U, a binary variable was used as previously described. Reduced models
were derived by model selection using the AIC with stepwise selection allowed in
both directions; models were successively revised so as to reduce AIC. A value
of p < 0.05 was considered statistically significant. Statistical analyses were
performed using R version 2.12.1 (The R Foundation for Statistical Computing,
2010, 64-bit).
The time and dose-response relationships of purified human LDL and metal
treatments were analyzed by two-way analysis of variance (ANOVA) followed by
the Dunnett multiple comparison test using GraphPad Prism 6.0 (GraphPad
Software, La Jolla, CA, USA). A value of p < 0.05 was considered statistically
significant.

RESULTS
Community-Level Association between Mining Metal Exposure and LDL
Oxidation
This Navajo subset is known to have a high prevalence of diabetes, hypertension
and overweight/obesity (Hund et al. 2015; Harmon et al, In submission). Table
3.1 shows clinical characteristics and biomarker levels by gender. Both genders
were similar in age and had similar TC, LDL cholesterol and non-fasting glucose
levels. Women were generally heavier, had higher HDL levels, lower TG, and
lower blood pressures than men. Both genders had similar median HbA1c
levels, but more women fell into pre-diabetic and diabetic categories of HbA1c
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Table 3.1 Navajo demographic and clinical characteristics by gender
Variable

Female (n = 145)

Male (n = 107)

55.5 (±14)

55.1 (±14.7)

Body mass index, kg/m²

31.2 (27.7-34.9)

28.2 (26.1-31.5)

Total Cholesterol, mg/dL

182.5 (163.3-201.8)

182 (159.5-204.5)

105 (90.3-123.8)

104 (88-122)

47.5 (39-57)

42 (34-49.5)

177 (127.5-247.3)

191 (125-261.5)

Systolic Blood Pressure (mmHg)

126 (114-142)

132 (121.5-145.5)

Diastolic Blood Pressure (mmHg)

76 (70-85)

81 (73-88.5)

Glucose (non-fasting), mg/dL

90 (77-122.8)

92 (79-120)

Median HbA1c, %

6.3 (5.9-7.3)

6 (5.6-6.9)

% Normal (≤ 5.6%)

7.7

26.4

% Pre-diabetes (5.7-6.4%)

50.3

39.6

42

34

45.7 (36.7-57)

48.7 (36.7-57.2)

2.5 (0.9-5.2)

1.8 (0.9-4.2)

44

32

Age (years)

Low Density Lipoprotein (LDL), mg/dL
High Density Lipoprotein, mg/dL
TG, mg/dL

% Diabetes (≥ 6.5%)
Oxidized LDL, U/L
C-Reactive Protein (CRP), mg/L
CRP > 3.0 mg/L, %

Data are presented as median (IQR) or %. HbA1c, glycated hemoglobin
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classification. Women had lower levels of oxLDL and higher CRP.

Median urine As [4.21 (2.25-6.78) μg/L] was below National Health and Nutrition
Survey (NHANES) 50th percentile [6.09 (5.22-7.12) μg/L] (CDC 2015; Table 3.2).
However, 14.6% of participants had urine U concentrations that exceeded
NHANES 95th percentile for all races, age, and gender by 4.2 fold. Median
values and IQR for other measured urine metals were: Cu, 12.45 (8.15-17.02)
μg/L; Ni, 13.08 (6.67-25.24) μg/L; and V, 1.05 (0.61-1.56) μg/L; NHANES values
for these urine metals are not presently available.

Overall median estimated mean annual water intakes for As and U were similar,
0.49 mg/year (IQR 0-1.09) and 0.46 mg/year (IQR 0-1.13), respectively. As and
U concentrations in drinking water ranged from 0-120 µg/L and 0-110 µg/L,
respectively. Water As intake was not correlated with urine As, and similarly
water U intake did not correlate with urine U (data not shown).

Reduced multivariate linear regression models for oxLDL are shown in Table 3.2.
Models 1 and 2 had very low adjusted correlation of determination (R2), however,
in both models estimated annual intake of water As (Water Asbi) was significantly
associated with oxLDL. In Model 2, water Ubi was also significantly but
negatively associated with oxLDL (p = 0.033). In Model 3, urine metals were
included (no interactions) and the adjusted R2 improved (0.106). Water Asbi
remained a positive predictor, and urine As was a marginally (p = 0.045) negative
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Table 3.2 Reduced regression models showing coefficient estimates for oxLDL
Coefficient
Model 1
Water Asbi
Model 2
Age, years
Female
Water Asbi
Water Ubi
Model 3
Water Asbi
Water Ubi
Urine As
Urine Ubi

Estimate

Standard
Error

P value

N
249

10.98
3.788
Adjusted R2 = 0.029, p = 0.004

0.004
249

-0.052
0.081
-1.12
2.288
10.05
4.232
-31.66
14.73
Adjusted R2 = 0.037, p = 0.02

0.526
0.625
0.018
0.033
94

15.9
7.086
-11.66
5.305
-3.889
1.916
11.68
4.392
Adjusted R2 = 0.106, p = 0.007

Model 4
Age, years
-1.568
0.823
Female
-54.19
24.07
Water Asbi
16.09
6.978
Water Ubi
-35.28
17.89
Urine As
-6.023
2.143
Urine Ubi
8.833
4.281
Urine Cu
-25.14
13.84
Female x Urine Cu
17.42
7.427
2
Adjusted R = 0.203, p = 0.002

0.027
0.031
0.045
0.009
94
0.06
0.027
0.024
0.052
0.006
0.042
0.073
0.021

P < 0.05 was considered statistically significant
Model 1: OxLDL modeled with physiological [age, gender, body mass index (BMI), glycated
hemoglobin (HbA1c)], and binary (bi) water intake variables [As (As), U (U)]
Model 2: Model 1, and 2nd order interactions with age and gender
Model 3: Model 1, and urine metals (As, Ubi, Copper (Cu), Nickel, Vanadium)
Model 4: Model 3, and 2nd order interactions with age and gender
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predictor of oxLDL; water Ubi remained a negative predictor and urine U was a
positive predictor (p = 0.009) of oxLDL. Model 4 seemed to best fit the data, but
the number of observations was reduced (n = 94; also for Model 3) due to the
limited data for urine Cu. In Model 4, adjusted R2 was higher (0.203) indicating
that including urine metals in the model is important. There was a significant
interaction for gender and urine Cu (p = 0.021) suggesting that women in this
Navajo with higher urine Cu have higher levels of oxLDL. Gender was a
negative significant predictor indicating that women have lower oxLDL, consistent
with what is shown in Table 3.1. Water Asbi again remained a positive predictor
(p = 0.024), but water Ubi was no longer significant (p = 0.052). Urine As was
again a significant negative predictor of oxLDL, and urine U remained a positive
predictor. BMI, HbA1c, and urine Ni and V did not appear as predictors in any
model.

Reduced multivariate linear regression models for log CRP are shown in Table
3.3. Models 1 and 2 had low adjusted R2 values (0.09). Age was a negative
predictor and BMI was a positive predictor in Models 1, 2 and 3, and in Model 2
the interaction of gender and BMI was marginally negatively correlated with log
CRP (p = 0.49). Adjusted R2 was improved in Model 3 (0.157) and further
improved in Model 4 (0.246), indicating that including urine metals is important.
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Table 3.3 Reduced regression models showing coefficient estimates for CRP
Coefficient
Model 1
Age, years
BMI, kg/m²

Estimate

Standard
Error

P value

0.002
-0.015
0.005
0.007
0.038
0.014
Adjusted R2 = 0.085, p = <0.0001

Model 2
0.001
Age, years
-0.016
0.005
0.058
Female
1.625
0.852
0.002
BMI, kg/m²
0.055
0.017
0.049
Female x BMI
-0.059
0.03
2
Adjusted R = 0.092, p = <0.0001
Model 3
0.011
Age, years
-0.019
0.007
0.115
Female
-0.327
0.205
0.026
BMI, kg/m²
0.049
0.022
2
Adjusted R = 0.157, p = 0.001
Model 4
0.706
Age, years
0.004
0.012
0.486
Female
-0.943
1.348
0.017
BMI, kg/m²
0.051
0.021
0.042
Urine U bi
-0.788
0.38
0.007
HbA1c bi
2.62
0.954
0.018
Age x HbA1c bi
-0.04
0.017
Female x Urine
0.031
1.296
0.589
U bi
Adjusted R2 = 0.246, p = 0.0003

N
247

247

94

94

P < 0.05 was considered statistically significant
Model 1: log CRP modeled with physiological [age, gender, body mass index (BMI), glycated
hemoglobin (HbA1c)], and binary (bi) water intake variables [As (As), U (U)]
Model 2: Model 1, and 2nd order interactions with age and gender
Model 3: Model 1, and urine metals (As, Ubi, Copper, Nickel, Vanadium)
Model 4: Model 3, and 2nd order interactions with age and gender
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Model 4 seemed to best fit the data, but the number of observations was reduced
(n = 94; also for Model 3) due to the limited data for urine Cu. In Model 4, there
was a significant interaction with gender and urine Ubi (p = 0.031) suggesting that
women with higher urine Ubi have higher levels of CRP. Urine Ubi was also a
significant independent predictor of CRP but the association was negative (p =
0.042). BMI continued to be a positive predictor of CRP, but age was removed.
HbA1c appeared in the model and was positively associated with CRP (p =
0.007). Water Asbi and Ubi and urine As, Cu, Ni or V did not emerge as
predictors in any of the models of CRP.

Acellular Studies of LDL oxidation
Protein oxidation of LDL cholesterol by As and U
Copper sulfate is a known oxidizer of LDL, and the CuSO4-treated LDL showed a
time and dose dependent response as expected, for CuSO4 concentrations
greater than 50 µM as compared to untreated LDL (Figure 3.1A). Sodium
arsenite appeared to directly oxidize LDL earlier at lower concentrations and later
at higher concentrations, but the level of oxLDL was similar at each time-point
(Figure 3.1B). Uranyl acetate (UA) only appeared to oxidize LDL at 3 hours, but
inconsistently at only the lowest (0.3 nM) and highest (300 nM) concentrations
(Figure 3.1C). Interestingly, in combined treatments, oxLDL levels were
increased at all time-points when both NaAsO2 and UA were present in the
reaction mixture (Figure 3.1D). Only the lowest combined
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Figure 3.1 Sodium arsenite directly oxidizes the apolipoprotein B
component of LDL cholesterol. (A) CuSO4 was used as a positive control.
Effects of different concentrations of (B) Sodium arsenite (NaAsO2); (C) Uranyl
acetate (UA), or (D) the combination of NaAsO2 and UA on the apoprotein B
(ApoB) of human purified LDL as measured by the 4E6 ELISA antibody.
*significant difference from LDL untreated. P < 0.05 was considered statistically
significant.
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concentrations of NaAsO2 (0.02 µM) and UA (0.3 nM) increased LDL oxidation to
the same level as LDL treated with NaAsO2 alone (0.07 µM), however, LDL
treated with the same concentration of NaAsO2 (0.07 µM) plus UA (0.3 nM) was
significantly lower than LDL treated with NaAsO2 alone at 1 and 2 hours but was
similar at 3 hours. LDL treated with 3 nM of UA alone was not significantly
increased but when the same concentration was combined with NaAsO2, LDL
oxidation was increased at all time-points. These data suggest that NaAsO2
directly oxidizes LDL, and that when combined, NaAsO2 and UA may additively
contribute to ApoB oxidation as measured by ELISA, especially at later timepoints in this experimental system.

Lipid peroxidation of LDL cholesterol by As and U
CuSO4 induced lipid peroxidation (MDA equivalents) of human LDL as expected,
with clear concentration- and time-dependent trends observed (Figure 3.2A).
The level of lipid peroxides was not affected by NaAsO2, UA, or the combination
of both metals (Figure 3.2 B-D) especially in comparison to CuSO4-treated LDL,
used repeatedly as a positive control (Figure 3.2A). These data suggest that
neither NaAsO2 nor UA promote lipid oxidation of LDL cholesterol under these
conditions.

Overall, these findings are coherent with our regression modeling data in that As
may promote increased LDL oxidation, however, it appears that As more likely
may contribute directly to the oxidation of the protein (Apo B)
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Figure 3.2 Sodium arsenite and uranyl acetate do not increase lipid
peroxidation of LDL TBARS assay with malondialdehyde (MDA) equivalents.
(A) CuSO4 was used as a positive control. Effects of different concentrations of
(B) NaAsO2 , (C) UA, or (D) the combination of NaAsO2 and UA on lipid
peroxidation of human purified LDL. *significant difference from LDL untreated; #
significant difference from LDL treated with NaAsO2 at 0.07 μM. P < 0.05 was
considered statistically significant.
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component and not the lipid components of the LDL particle. U seems to be
associated with oxLDL but the relationship is unclear.
DISCUSSION
We investigated whether CVD biomarkers, oxLDL and CRP, were
associated with annual estimated drinking water intake of As and U, as
representative mining metal contaminants. To establish proof-of-concept, we
also assessed if these metals could directly oxidize LDL. Both data sets are
consistent with the hypothesis that As may promote oxidation of LDL, a crucial
step in vascular inflammation and chronic vascular disease. Outcomes related to
U were also consistent, in that negative associations were observed between U
intake from water and oxLDL, and U only
minimally altered human LDL in direct exposure experiments. Urine As and U
were also associated with oxLDL, albeit in opposite directions from each other
and from the water intakes of these metals. Only urine U seemed to have an
association with CRP whereas no other metals in water or urine were predictors
of this inflammatory marker.

Numerous epidemiological studies have shown that As contributes to CVD
development, but limited evidence is available for As effects on the intermediate
biochemical changes associated with atherogenesis. Recently, chronic As
exposure from drinking water has been associated with biomarkers of
inflammation and endothelial cell activation including oxLDL, the ratio of oxLDL
with HDL, CRP, ICAM-1 (Karim et al 2013) and VCAM-1 (Wu et al. 2012) in
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Bangladesh residents. Another recent study in Bangladesh showed that As
exposure was associated with increased plasma CRP, especially in participants
with greater plasma glutathione redox potential (Peters et al. 2015).

OxLDL contains heterogeneous lipid and protein components that vary in degree
and type of oxidation that can induce a variety of pro-atherogenic effects (Reis et
al. 2015). Our data suggest that As, in direct contact with LDL particles, can
modify the ApoB 100 component in a manner that makes it recognizable by the
4E6 antibody. While As has been shown to promote chronic vascular
remodeling, there is conflicting evidence whether As increases lipid peroxide
levels in ApoE-/- mice (Simenova et al. 2003; Srivastava et al. 2009). In the
present study, As had minimal acute effects on lipid peroxidation of purified
human LDL. Minimally-oxidized LDL is sufficient to promote vascular
inflammation and pathological remodeling, and is typically characterized by ApoB
oxidation with lower levels of TBARS (Itabe et al. 2003). The direct interaction of
As with ApoB may, however, be sufficient to drive the minimally-oxidized form of
oxLDL and thereby play a role in systemic vascular disease.

It remains unknown how metals such as As and U may influence oxidative
modifications of LDL. As is redox inactive but has an affinity for thiol-containing
molecules (Jomova and Valko 2011). The ApoB-100 protein component of LDL
contains cysteine residues (Segrest et al. 2001) that could potentially be modified
by As. As is also known to bind hemoglobin on erythrocytes as well as other
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proteins in the plasma, including thioredoxin and glutathione (Hughes et al. 2011;
Schmidt et al. 2009), which may influence the bioavailability and
pharmacokinetics of As as well as influence the behaviors of the bound-proteins.

Little is known about the effects of chronic low-level exposure to U, particularly in
terms of CVD prevalence and pathogenesis. Exposure to depleted U is
associated with increased lipid oxidation in rat brains (Briner and Murray 2005)
and the limited studies on endothelial cells toxicity are negative (Dobson et al.
2006). However, our results suggest that in an isolated acellular system, low
concentrations of U do not directly modify either the protein or lipid components
of LDL, and U seemed to reduce the oxidizability of the ApoB 100 protein by As.
Furthermore, measures of U in drinking water associated negatively with oxLDL
and not at all with CRP levels in the Navajo population. An important
consideration for mine wastes is the mixture of metal contaminants, not simply
the residual ores of interest, which can be most toxic to exposed populations.
Thus, while the vast majority of abandoned mine sites in this region were a result
of U extraction, numerous other metals such as As, V, Ni, and Cu may be left
behind creating a legacy environmental health risk.

While our findings indicate the potential for direct effects between metal
contaminants and LDL oxidation, the contribution of indirect effects should not be
dismissed. Increased levels of reactive oxidants and decreased antioxidant
capacity have been found in plasma from humans exposed to As in drinking
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water (Wu et al. 2001). Changes in redox status or increased free radical
production (Lankin et al. 2014) and inflammatory factors may be induced by the
presence of toxic metals in plasma or atherosclerotic lesions (Shi et al. 2004).

Limitations
The cross-sectional nature of our analysis does not allow for temporal relations
between exposure and CVD outcomes to be established, however, this is the first
epidemiologic study to demonstrate that As promotes LDL oxidation in an
exposed population in the U.S. Selection bias is a possibility in this volunteer
population; however, no obvious biases in exposure risks have been found
(deLemos et al. 2009; Hund et al. 2015). Participants represented the full range
of exposures including a significant proportion of unexposed volunteers,
improving the generalizability of our results (Hund et al. 2015). Blood samples
were non-fasting, and medication use was not included in this initial analysis,
which could influence LDL modifications. Because of the long storage times, we
were unable to assess TBARS in the banked serum from the DiNEH study as a
parallel to the acellular assays.

Epidemiological study designs prevent conclusions of causality and provide
limited mechanistic information. In order to establish biological plausibility, we
performed proof-of-concept acellular assays, which were chosen to represent
direct oxidation of LDL by As and U in the circulation thereby contributing to the
atherosclerotic process, but this could also represent what may be occurring
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within developing lesions. It is thought that most modifications to LDL probably
occur in situ within the atherosclerotic lesion (Itabe et al. 2011), and more
research is needed to assess whether As and/or U can accumulate in vulnerable
vascular lesions.

Several metals, including As, have been detected in atherosclerotic lesions and
cardiovascular tissue (Simeonova et al. 2003; Stadler et al. 2004). Importantly,
our acellular data match what was observed in the human serum, in terms of
ApoB modifications. Lastly, although the buffers used in these experiments (PBS
and HEPES) are stable and non-reactive, they do not share the same milieu of
factors that may contribute to the atherosclerotic process or affect metal-LDL
interactions, such as anti-inflammatory factors and metal-binding or carrier
proteins, respectively.

Conclusions
These findings suggest that As intake from contaminated drinking water may
influence oxidative modifications of low-density lipoproteins in the Navajo
population. Direct oxidation by metals may be an overlooked contributing
mechanism to explain chronic CVD health outcomes, although future research
will need to explore such relationships in more physiologically-relevant
experimental systems. For the Navajo community, new mining sites are planned
(e.g. near Grants, New Mexico), and there remains a dearth of literature
exploring the potential health effects of unremediated wastes and tailing from
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mining operations. Continued research into mining waste-related community
health outcomes, and pathophysiological basis thereof, is essential to ensuring
that mineral resources can be extracted with minimal negative impacts on
ecological and public health.
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IV. CHAPTER 4
Abandoned U Mine Proximity Predicts Endothelial Inflammatory Potential of
Serum from Chronically Exposed Navajo Communities

In preparation for submission
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ABSTRACT
Members of the Navajo Nation reside at varying distances from hundreds of
AUMs, which contribute U, As and other metals to the soil, water and air. These
contaminants continue to pose potential health risks to these communities where
the prevalence of inflammatory-related health conditions including coronary
artery disease, metabolic syndrome and hypertension have increased in recent
decades. Endothelial cells, essential players in the development of coronary
plaques, respond to cumulative circulating pro- and anti-inflammatory mediators
in a manner that reveals the balance of inflammation, i.e. inflammatory potential,
which we define as the changes in transcriptional responses of inflammatory
markers from primary endothelial cells treated in vitro with serum derived from
exposed populations. Our goal was to determine the contribution of AUM waste
exposures to community-level serum inflammatory potential. Serum was
obtained from a subset of Navajo volunteers (n = 145). Transcriptional
responses of VCAM-1, ICAM-1, and CCL2 were measured from Navajo serumtreated primary endothelial cells and linked to AUM proximity and mean annual
As and U intakes from water using linear regression. Linear regression modeling
showed that household AUM proximity strongly predicted CCL2, VCAM-1 and
ICAM-1 mRNA (p = <0.0001 for each response) from endothelial cells treated
with serum from exposed Navajo participants, whereas annual water intakes of
As and U did not. In summary, this is the first application of this novel measure
of cardiovascular health in a community population. Our data reveal a broader
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effect of mining waste exposure on overall inflammation, and routes of exposure
beyond drinking water should be investigated.
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INTRODUCTION
One of the richest U ore deposits in the United States, located in the Four
Corners region of the Southwest, was actively mined on the Navajo Nation
between the 1940s and 1980s (McLemore 2010). Today, there are more than
500 AUMs and 4 mill sites that continue to pose a risk to these communities
(deLemos et al. 2009). U, As, Ni, V and Cu are among the major contaminants
still found in the soil, air and ground water to which this population may be
chronically exposed (Blake et al. 2015). The impact of such exposures on
cardiovascular disease remains poorly researched.

American Indians, including Navajo, are known to have a high prevalence of
inflammatory conditions including cardiovascular disease, hypertension,
diabetes, and obesity (Nava et al. 2015). As such, there is concern that this
population may be vulnerable to added cardiovascular stressors, such as
environmental contaminant exposure. Recent studies have found a small link
between As in the drinking water and the levels of oxidized LDL cholesterol
(Harmon et al. 2015). However, assessment of single circulating factors (e.g.,
cytokines, etc.) may fail to capture the overall inflammatory and pathological
influence that all circulating components convey to the endothelial wall.
Endothelial cells respond to cumulative circulating pro- and anti-inflammatory
mediators in a manner that reveals the balance of inflammation, i.e.,
inflammatory potential, which we define as the transcriptional responses of
inflammatory markers in primary endothelial cells treated in vitro with serum
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derived from human subjects (Smoliga et al. 2013). Endothelial cell expression
of adhesion molecules and chemokines (e.g., CCL2 or monocyte
chemoattractant protein-1) is a principal activity in the pathogenesis of chronic
atherosclerotic vascular disease (Aird 2008; Aukrust et al. 2008).

In humans, serum inflammatory potential, as determined by stimulation of
responses in human primary coronary artery endothelial cells (hCAECs), has
been linked directly to cardiovascular disease (Cung et al. 2015) as well as to
inhalation exposures to diesel emissions (Channell et al. 2012; Schisler et al.
2015). Furthermore, it has been reported that polyphenols (namely resveratrol),
as a nutraceutical treatment, led to reduced serum inflammatory potential in
healthy subjects, as compared to placebo (Agarwal et al. 2013). Such studies
are coherent with animal toxicological research showing that the inhalation of
various toxicants, including gases and particles, leads to inflammatory and antidilatory alterations in the serum composition (Aragon et al. 2015; Paffett et al.
2015; Robertson et al. 2013).

In the present study, we assessed the inflammatory potential of serum from a
population of Navajo community members. We hypothesized that serum
inflammatory potential would be adversely influenced by exposure to AUMs in
the Southeastern corner of the Navajo Nation. While drinking water was also
considered as an exposure route, linear regression models showed that simple
proximity to AUM had a strong and independent influence in the overall serum
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inflammatory potential. This is the first application of this novel and unbiased
metric of cardiovascular health in a community population.

METHODS
Study Population
Demographic, water use and clinical data were obtained in partnership with the
Diné Network for Environmental Health (DiNEH) Project (deLemos et al. 2009)
using the Water and Land Use, Environmental and Health Survey. Surveys were
administered in interview fashion to a cohort of 1,304 participants from 20
Chapters of the Navajo Nation between 2005 and 2010. A volunteer subset of
this population (n = 145) provided non-fasting serum samples between 20102011 at which time height and weight were also measured to determine BMI; all
data for the current study was derived from this volunteer subset. All participants
provided informed consent, with oversight and approval from the UNM Human
Research Review Committee and the Navajo Nation Human Research Review
Board.
Geospatial data
The locations of the homes of the survey participants were determined by using a
hand-held Global Positioning System (GPS) instrument. The mean duration of
residence in a current home was 32.1 years. The locations and surface areas (in
m2) of the abandoned U mines and mills within the study area were obtained
from the U.S. Army Corps of Engineers documentation compiled for the USEPA
(USEPA, 2007a).
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Exposure metrics
Mean annual water intakes of As and U were estimated as previously described
in Chapter 3 (p. 67-69).

AUM proximity was calculated as the log of the sum of the inverse distances of
participant reported household geographical location to all AUM features (portals,
prospects, rim strips, pits, vertical shafts or waste piles) in the study area,
weighted by the surface area of each feature. The formula is noted below:
parti denotes the geographical position of participant i. mj denotes the
geographical position of abandoned mining site j. N is the number of abandoned
mining sites used in this formula. areaj is the area of mining site j in square
meters. The formula for AUM for participant i is then

𝑁𝑁
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Inflammatory Potential Assay and Transcriptional Responses
The inflammatory potential assay (Figure 4.1) was conducted as previously
described (Agarwal et al. 2013; Cung et al. 2015). Briefly, hCAEC (Lonza;
Allendale, NJ) were grown to confluence in complete media on a series of 2485

.

Figure 4.1 Schematic of serum inflammatory potential assay. Primary
human coronary artery endothelial cells were incubated with complete serum
from study participants for 4h, after which endothelial cell responses were
assessed by RT-qPCR for ICAM-1, VCAM-1, and CCL2
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well plates. For 24 hours prior to serum treatment, the cells were serum-starved
with Basal Media (Lonza). Confluent hCAECs were then incubated with 10%
serum (vol:vol) obtained from DiNEH volunteers (n=145). The samples were
incubated for 4 hours at 37°C. Human CAECs were washed with PBS, lysed,
and cell lysates were immediately collected for RNA purification. Total RNA was
isolated from samples using RNeasy Mini Prep Kits (Qiagen), and RNA was
reverse transcribed using High Capacity cDNA Reverse Transcription Kits
(Applied
Biosystems) prior to quantitative real-time PCR (qPCR) assessment of
endothelial adhesion markers. Amplification of target message was performed in
TaqMan Universal Master Mix according to manufacturer’s recommended
conditions with TaqMan gene expression assays for intercellular adhesion
molecule 1 (ICAM-1; Hs00164932_m1), vascular cell adhesion molecule 1
(VCAM-1; Hs01003372_m1), and chemokine (C-C motif) ligand
(CCL2; Hs00234140_m1), with TATA box–binding protein (TBP;
Hs00427620_m1) as the endogenous reference gene (Applied Biosystems
7900HT). Relative gene expression was analyzed by the 2−ΔΔCT method using a
relative amount of mRNA for each sample normalized to TATA box–binding
protein (Livak and Schmittgen 2001).
Statistical Analysis
Descriptive summary statistics were reported as median and IQR for continuous
variables, unless otherwise indicated. Non-Gaussian distributions were
normalized using a logarithmic transformation. Distributions for untransformed
87

CCL2, ICAM-1 and VCAM-1 mRNA are shown in Fig 4.1S. Pearson correlations
were performed to assess the relationship of CCL2, ICAM-1 and VCAM-1 mRNA
to other CVD risk factors and biomarkers. Linear regression models were used
to link the endothelial mRNA transcriptional responses (ICAM-1, VCAM-1, and
CCL2) from the inflammatory potential assays as response variables to the
exposure metrics including AUM proximity and annual As (As) and U (U) intakes
from water and potential confounders age, gender, BMI and HbA1c. Estimated
annual intake of As and U from drinking water sources were binary variables (as
described in Chapter 3, p. 69). Reduced models were derived by model
selection using the AIC. A value of p < 0.05 was considered statistically
significant for models and their component variables. Statistical analyses were
performed using R version 2.12.1 (The R Foundation for Statistical Computing,
2010, 64-bit) and GraphPad Prism 6.0 (GraphPad Software, La Jolla, CA, USA).
RESULTS
Demographic and clinical characteristics of the DiNEH subset are shown in Table
4.1. The mean age was 56 years (S.D. 14.8), and females represented 38% of
this Navajo subset. Median BMI was 30 kg/m2 with more than a third of this
subset (34.5%) being overweight and 50% were obese. In the original DiNEH
study of 1304 participants, 41.2 % were obese (Harmon et al., 2015 in press) but
a similar percentage was overweight. Median TC and LDL were within
recommended guidelines based on American Heart Association guidelines
(National Cholesterol Education Program Expert Panel on Detection and
Treatment of High Blood Cholesterol in 2002). HDL cholesterol was somewhat
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Table 4.1 Characteristics of DiNEH participants
Variable
Age, years
Female, %
Body mass index (BMI), kg/m²
Normal (BMI = 18.5-24.9), %
Overweight (BMI = 25.0-29.9), %
Obese (BMI ≥ 30), %
Total Cholesterol, mg/dL
Low Density Lipoprotein, mg/dL
High Density Lipoprotein, mg/dL
TG, mg/dL
Systolic Blood Pressure (mmHg)
Diastolic Blood Pressure (mmHg)
Glycated hemoglobin (HbA1c), %
% Normal (≤ 5.6%)
% Pre-diabetes (5.7-6.4%)
% Diabetes (≥ 6.5%)
Estimated mean annual intake from water
As (mg/year)
U (mg/year)

56.1 (SD 14.8)
38
30 (26.8-34.0)
14.8
34.5
50
185 (164-204)
105 (91.5-121.5)
45 (38-55)
184 (130-263)
129 (116-144)
78 (72-87)
6.2 (5.8-7.6)
16
42.7
41.3
0.83 (0-1.15)
0.82 (0-1.14)

n
145
145
142

127
127
127
125
143
143
143

144
144

Data are presented as median (IQR) or %, except where noted. Abandoned U Mine (AUM)
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low, and TG were elevated. Median systolic blood pressure was prehypertensive, but median diastolic blood pressure was normal (Chobanian et al.
2003). Median glycated hemoglobin (HbA1c) was in the pre-diabetic range as
defined by the American Diabetes Association (American Diabetes 2012). Over
80% of this subset was pre-diabetic or diabetic based on HbA1c. Estimated
Navajo subset. Median BMI was 30 kg/m2 with more than a third of this subset
(34.5%) being overweight and 50% were obese. In the original DiNEH study of
1304 participants, 41.2 % were obese (Harmon et al. 2015 in press) but a similar
percentage was overweight. Median TC and LDL were within recommended
guidelines based on American Heart Association guidelines mean annual As and
U intakes from water for this subset were both about 0.8 mg/year.

Figure 4.2A shows a heat map of the study area and area-weighted proximity to
abandoned U mine and mill sites. AUM proximity distribution is shown in Figure
4.2B. Median AUM proximity was 0.207 (IQR 0.179-0.224). Univariate analysis
(Table 4.2) showed that the weighted (based on surface area) proximity to AUM
was significantly correlated with all endothelial transcriptional inflammatory
markers (Fig 4.2S). CCL2, ICAM-1 and VCAM-1 mRNA were positively and
significantly correlated with each other, which is consistent with their roles as
inflammatory response mediators. Age, gender, BMI, HbA1c, lipids, and systolic
or diastolic blood pressures were not correlated with any of the transcriptional
responses. Final reduced regression models are shown in Table 4.3. Of all the
variables used as potential predictors, the one strong independent predictor of
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A

B

Figure 4.2 Study area heat map and frequency distribution of AUMs A) Study area and heat
map of area-weighted proximity to abandoned U mine and mill sites. The Southeastern region of
the Navajo Nation sits within the Northwestern portion of New Mexico and contains approximately
100 mine sites. B) Frequency histogram showing distribution of Navajo participants’ household
weighted proximities to abandoned U mines (AUM), with higher numbers indicating more
proximal residences

91

Table 4.2 Pearson correlations between mRNA transcriptional responses and demographic and clinical risk factors and
exposure metrics
VCAM1
ICAM1
CCL2
Variable
p
p
p
r
r
r
0.572 -0.037
0.657
0.93
Age
-0.047
0.007
Gender
0.072
0.39
0.066
0.429
0.02
0.813
0.409 -0.082
0.333
0.229
BMI
-0.07
-0.102
Total Cholesterol
0.285
0.161
0.703
0.096
0.125
0.034
(mg/dL)
0.277
0.311
0.766
LDL (mg/dL) Direct
0.098
0.091
-0.027
HDL Cholesterol
0.13
0.068
0.999
0.135
0.162
-0.0001
(mg/dL)
0.888
0.715
0.131
TG (mg/dL)
-0.013
0.033
0.135
0.756 -0.071
0.397
0.813
SBP (mmHg)
-0.026
-0.02
0.989 -0.005
0.952
0.917
DBP (mmHg)
0.001
-0.009
0.825
0.968
0.441
HbA1C (%)
-0.019
0.003
0.065
0.213 -0.117
0.176
0.122
IL-6 (pg/ml)
-0.108
-0.134
0.239 -0.182
0.221
CRP (mg/L)
-0.099
0.029
-0.103
0.298
0.129
0.059
Water U*
0.087
0.127
0.157
0.317
0.37
0.185
Water As*
0.084
0.075
0.111
AUM Proximity
0.226
0.006
0.378 <0.0001
0.471 <0.0001
Pearson correlation coefficients (r). P < 0.05 was considered statistically significant (bold). *continuous variable. Non-Gaussian distributions were
log transformed. LDL, low-density lipoprotein; HDL, high-density lipoprotein; HbA1c, glycated hemoglobin; CRP, C-reactive protein; IL6, interleukin
6, SBP, systolic blood pressure; DBP, diastolic blood pressure; BMI, body mass index; U, U; As, As; AUM, abandoned U mine
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Table 4.3 Reduced regression models showing AUM proximity is the sole predictor of endothelial mRNA responses to
serum from Navajo participants

Coefficient
Estimate of
AUM
Proximity

Standard
Error

p-value

Adjusted
R2

p-value
of model

VCAM-1

5.582

1.304

3.41E-05

0.107

< 0.0001

ICAM-1

5.335

0.964

1.45E-07

0.171

< 0.0001

CCL2

6.954

1.142

9.99E-09

0.2

< 0.0001

Endothelial
Response
Variable

Reduced models are shown. Age, gender, body mass index, glycated hemoglobin, and water intake variables as potential predictors
dropped out of models after model selection. Chemokine (C-C motif) ligand 2 (CCL2); intercellular adhesion molecule 1 (ICAM-1);
vascular cell adhesion molecule 1 (VCAM-1); Abandoned U Mine (AUM).
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endothelial mRNA transcriptional responses was AUM proximity. The
associations were strong and positive for all responses (p < 0.0001). The highest
R2 (adjusted) was 0.20 for CCL2, followed by 0.17 for ICAM-1 and 0.11 for
VCAM-1. Age, gender, BMI, HbA1c and estimated annual water intakes of As
and U dropped out of the model.

DISCUSSION
Proximity of residence to AUMs has a strong influence on the degree of
inflammatory potential in the circulation of Navajo community participants in the
present study. Although the power of the final models was not large (adjusted R2
values for the final models were 0.107 for VCAM-1, 0.171 for ICAM-1, and 0.200
for CCL2), considering the known influence of genetic and lifestyle factors on CV
health, and the high prevalence of obesity and diabetes in the Navajo, these
numbers indicate that AUM proximity has significant predictive power for these
endothelial transcriptional responses to serum. In previous work with patients
who had previously experienced a major cardiac event (infarction or angina), we
saw comparable influences of risk factors on serum inflammatory potential (Cung
et al. 2015). While a head-to-head comparison across these studies is not valid
because of the differences in the demographics, the correlation coefficients (R)
for proximity to AUM and endothelial inflammatory responses were comparable
and even greater than the reported influences of inflammatory markers such as
CRP, circulating lipids, and incidence of diabetes. Thus, the degree of
association between proximity to AUMs and circulating inflammatory potential is
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striking.
In our previous assessments of individual cardiovascular disease markers in this
Navajo population, we found only a modest influence of the drinking water levels
of As on oxidized LDL, with no association between exposure and CRP (Chapter
3, p. 76-78) or IL6 (data not shown). However, the data for As in the water was
limited for the vast majority of this study population and effects were driven by
less than 10% with the highest As levels. The present data reveals a broader
effect of mining waste exposure on what we believe to be a more sensitive and
reliable metric of overall inflammation than single cytokines or acute phase
protein measures. Proximity to AUMs, and not our estimates of oral As or U
intake, associates strongly with the serum-stimulated responses of ICAM-1,
VCAM-1 and CCL2 mRNA. This relationship suggests that alternate exposure
pathways or indirect health impacts are induced by the presence of the AUMs.
Potentially windblown dusts from unremediated surface mines may present a
hazard of metal-rich particulate matter, which is a known driver of cardiovascular
toxicity (Bell et al. 2009; Lippmann et al. 2006; Niu et al. 2013). Windblown
events and Aeolian transport of such contaminated dusts have been increasing
and climate change models predict this trend to continue in the foreseeable
future (Munson et al. 2011; Stovern et al. 2014).

We assume that changes in circulatory inflammatory potential are, in the short
term, temporary and reversible (Agarwal et al. 2013). Factors that contribute to
life-long risk of cardiovascular disease, such as smoking, poor diet, sedentary
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lifestyle, often are reversible in the short term (Estruch et al. 2006; Lessiani et al.
2015; Xu et al. 2013), but chronic unrelieved adverse behaviors and exposures
will ultimately lead to vascular inflammation and irreversible remodeling. On the
assumption that our findings reflect a causal relationship between exposure and
circulating inflammatory potential, relocation of residence or remediation of such
sites could therefore allow for reversal of this cardiovascular stressor. Any
vascular plaque development up to that intervention, however, would not likely
reverse. Importantly, this is a population with a high degree of residential stability,
with the average participant having a residence time of greater than 30 years.

Limitations of this novel assay and, by extension, the study conclusions relate
primarily to the lack of quantitative reference data due to the responses of
different batches and passages of endothelial cells being difficult to compare
across studies. Unlike measurement of circulating proteins, which have a clear
unit of concentration, the present data are derived from a single origin of
endothelial cells and normalized within the study population. While quality
control protocols are in place to ensure that Ct values are within acceptable
ranges for all studies, it would not be feasible to conduct head-to-head
comparisons of the present data with previously published data, although withinstudy trends are certainly comparable in a broader sense. Additionally, as this
assay remains novel, pure risk estimates of cardiovascular disease are not
available. Unlike CRP protein or IL6, which have been characterized thoroughly
in numerous large population studies (Framingham; NHANES; etc) (Bennet et al.
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2003; Rutter et al. 2004; Wang et al. 2002), such extensive association to CVD
outcomes in a large cohort has yet to be conducted for the present study. Study
limitations related to the population have been previously addressed (Harmon et
al., 2015, in press), but include a potential for self-selection and the lack of a
clear unexposed population, although this study of 145 participants reflects a
broad continuum of exposure and includes participants from regions of the
Navajo Nation with no mining history. Because the Navajo population has
unique genetic and cultural characteristics, comparisons with populations much
farther from the Navajo Nation region (and AUMs) would be challenging if not
impossible to properly match.
Finally, endothelium subjected to chronic exposures may not respond in kind with
naïve endothelial cells in culture, however, this does not detract from the
observation that detectable differences exist in endothelial responses to serum
from unexposed versus exposed subjects. Serum represents not only the
balance of inflammation but also adaptive responses (Williams and Iatropoulos
2002) by the endothelium to chronic exposures over time that often co-occurs
with chronic disease progression. Endothelial activation serves as an important
end point that shows potential for assessing CV health beyond traditional
biomarkers and risk factors. More studies are needed to assess endothelial
responses to serum from larger, chronically exposed populations with and
without disease at different points in time. Additionally, future studies should also
examine changes in endothelial expression and function that could occur with
more chronic serum treatment times.
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Despite some limitations, we have applied a novel and unbiased approach to
assess endothelial activation by cumulative circulating inflammatory components
using serum from community members overburdened by chronic CV health
conditions with legacy mining exposures. This study supports the emerging idea
that changes in serum composition caused by chronic toxic exposures, and
transmitted by circulatory signals to the endothelium, can promote vascular
inflammatory responses, although further study is needed to confirm any causal
link between the exposures and health outcomes.
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SUPPLEMENTAL INFORMATION
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Figure 4.1S Distribution of relative endothelial mRNA expression responses to
serum from Navajo participants
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Figure 4.2S Plots of AUM proximity with fold change expression and endothelial
responses to serum treatment
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V. Chapter 5
Conclusions and Future Directions
I.

Demographic Associations with Oxidized LDL

Conclusion
In the first study, our primary objective was to evaluate circulating levels of the
novel CVD biomarker, oxLDL, from a cross-sectional population of the Navajo
Nation (DiNEH Project), as oxLDL had never been assessed in a Native
population. We also compared levels of oxLDL with other populations from
studies that used the same antibody to measure oxLDL. We examined the
relationship of oxLDL, and ratios of oxLDL to both HDL and LDL, to more
conventional CVD risk factors and biomarkers. We were also able to provide
updated information on the prevalence of CVD-related health conditions in this
population.

Mean oxLDL levels in the DiNEH subset were similar to levels of oxLDL in
subjects from previous studies with no detectable CAD. The DiNEH subset also
appeared to have moderate dyslipidemia, evidenced by high TG and low HDL;
however, LDL levels were near normal. OxLDL and oxLDL-ratios were correlated
with CRP, but only the ratios were significantly correlated with HbA1c.
Multivariate analysis showed that CRP and HbA1c were not predictive of oxLDL
itself, but CRP was predictive of oxLDL/LDL and HbA1c was predictive of
oxLDL/HDL. The relationship of oxLDL to other CVD-risk factors in this high-risk
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group is unclear, therefore oxLDL may be a unique, independent biomarker,
thus, relationships of CVD outcomes with oxLDL would be merited.

Obesity, hypertension, pre-diabetes, and diabetes (as measured by self-report
survey data and BMI, blood pressure, and HbA1c, respectively), were prevalent
in the Navajo population, consistent with earlier findings and likely more
prevalent than previous studies have shown (Mendlein et al. 1997; Will et al.
1997). This population potentially also has a high prevalence of metabolic
syndrome, based on criteria for this condition (Grundy et al. 2004; Schumacher
et al. 2008), although this has not been directly measured. Navajo who had a
diagnosis of diabetes at the time of survey appeared to have high (pre-diabetic
and diabetic) HbA1c levels from subsequent blood draws up to 5 years later,
suggesting that their diabetes is not being managed well (only 25% reported
using insulin or other medication), further increasing the risk of CVD. It seems
likely that the levels of oxLDL in this population will rise as the severity of CVDand diabetes-related risk factors increase, especially without proper
interventions. It is also known that populations with CVD-related conditions are
more susceptible to environmental toxins.

Future Directions
The biggest gap in our study is that we have not done a long-term health study
from which we can link oxLDL to CVD morbidity and mortality. This initial
evaluation of oxLDL and the relationship to CVD risk factors applied relatively
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facile statistical analyses due in part to the cross-sectional nature of the study
(i.e. no longitudinal data or comparative population). It would be interesting to
look more deeply at the data from this subset. For example, percentiles of
various biomarkers (HbA1c or BMI) could be compared (t-tests, ANOVA)
between genders and across age groups to discern if certain segments of the
population are more at risk and potentially make comparisons with other native
populations (e.g. Strong Heart Study, Navajo Health and Nutrition Survey). It
also might be worth comparing some data from studies that have previously
investigated health measures from Native populations that have accessible
databases (Pima Indians, Strong Heart Study).

Additionally, there are other unexplored socioeconomic and lifestyle risk factors
that may contribute to the cardiometabolic disease seen in this population that
could be evaluated for potential interactions. Socioeconomic status, smoking,
and dietary practices (for which some data is available for this subset) are
commonly included in regression analysis as potential confounders and could
have significant impact on health status. The majority of Navajo incomes are
reportedly below the poverty line, opportunities for employment are minimal, and
there is lack of access to health care and education, although this has improved
in recent years (Diné Policy Institute 2014). Smoking tends to be uncommon
except for ceremonial use, but alcohol use is prevalent despite being illegal on
the Navajo Nation (Kunitz 2006), and has often been overlooked in previous
Native population studies (Lu et al. 2003). Finally, the Navajo Nation is
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considered a rural “food desert” due to lack of access by the population to
adequate nutrition, which can drive disease and influence susceptibility to
toxicants (Diné Policy Institute 2014). Understanding all of these risk factors and
how they relate to each other will help in better assessing CVD risk in this
population.

Many native populations, including Navajo, have historically had lower
cholesterol levels as well as low a incidence/prevalence of CAD, myocardial
infarction and stroke (Howard 1998). Diabetics also have lower serum antioxidant
capacity and dysfunctional HDL (Gowri et al. 1999). Dyslipidemia with normal
LDL is common in metabolic syndrome (Howard et al. 2000), and LDL derived
from diabetics is more susceptible to oxidation (Vergès 2009). One explanation
for the normal level of LDL but a high prevalence of CVD-related conditions and
risk factors could be that the composition of the LDL particle itself is more proatherogenic, e.g. “small dense LDL”, which can pass more easily into the intima
and be more easily oxidized (Vergès 2009). Thus, although LDL may be at a
normal level, it may also be more susceptible to oxidation further increasing CVD
risk in this population. It would therefore be of interest to determine LDL particle
size in this population on a portion of the remaining serum (polyacrylamide
gradient gel electrophoresis). Smaller oxLDL particles would theoretically
associate more closely with ongoing inflammatory disease and/or increased risk
of adverse CVD outcomes. It has been suggested that lipid management in
metabolic disorders may need more aggressive treatment. In order to address
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questions like these, the need exists for a larger longitudinal CVD outcomes
study of the Navajo population which has not been included Framingham or
similar studies thus far (D’Agostino et al. 2001).
II.

Relationship Between AUM Exposure Metrics and oxLDL

Conclusion
Having studied the general demographic predictors of oxLDL in the Navajo
participants, our next objectives were two-fold. First, we assessed if As and U
exposure from drinking water (as binary variables described in Chapter 3, p. 69)
would be associated with circulating inflammatory markers including oxLDL and
CRP using linear regression modeling in a subset of the DiNEH study population.
Second, we determined whether As (NaAsO2) and U (UA) could increase the
oxidation of purified human LDL directly, including both the protein (ApoB 100)
protein and lipid (represented by MDA) components of LDL.
Median estimated mean annual water intakes for As and U were similar, 0.49
mg/year (IQR 0-1.09) and 0.46 mg/year (IQR 0-1.13), respectively, although
these have not been calculated per body weight in kg thus far which would not
account for other routes of exposure. On the other hand, nearly 15% of subjects
had urine U concentrations that exceeded NHANES 95th percentile. It is
unknown if urine Cu, V, and Ni were similar to other populations, as Cu levels in
urine are not available in NHANES and urine levels of V and Ni are mainly
available for occupationally exposed populations. Kidney disease could affect
excretion of As (urine levels; Zheng et al. 2015). In this subset, associations
between biomarkers or renal function/pathology and urine metals have not been
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evaluated. Also, we were unable to obtain different species of metals,
particularly As, from urine samples.

The models differed substantially between oxLDL and CRP. All four reduced
multivariate linear regression models for oxLDL (dependent variable) indicated
that As intake (Water Asbi) was a significant independent predictor of oxLDL. It
was important to include age and gender interactions and urine metals despite
the reduced subject number due to fewer available Cu biomonitoring data). The
only other urine metal influencing the model was Cu in an interaction with
gender. Men and women may behave differently leading to different types of
exposures and/or differences in ability to detoxify ingested metals. BMI, HbA1c,
and urine Ni and V did not appear as predictors in any model.

For reduced multivariate linear regression models for CRP, it was again
important to include age and gender interactions and urine metals as these
models better fit the data and had higher adjusted R2. The only metal to appear
as a predictor in any model of CRP was urine U in an interaction with gender,
suggesting that women with higher urine Ubi have higher levels of CRP. Urine Ubi
alone was a negative predictor of CRP. BMI appeared as a predictor in each
model, consistent with previous literature (Weyer et al. 2002), and suggests that
subjects with higher BMI have an increased inflammatory status. Age was a
negative predictor in all but the fourth model. HbA1c only appeared in the fourth
model and was positively associated with CRP.
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Diabetes is associated with CVD as well as As exposure (Kim et al. 2013), and
the association of As with CVD mortality has been shown to be greater in
diabetic participants (Solenkova 2014). We also assessed HbA1c as a response
variable (data not shown) as well as a covariate of oxLDL, but we did not find any
associations with exposure, or as an interaction with exposure, respectively.
However, the majority of the study population was pre-diabetic or diabetic, with
only a small number of participants having healthy HbA1c levels. It is unknown
at present if other comorbidities could influence our results. Also, there is no
time course or explicit control group, and epidemiological approaches are limited
in that they do not allow for causation.

NaAsO2 increased LDL oxidation as measured by ELISA, but this did not appear
to be dose- or time-dependent in this experimental system. UA oxidized LDL
only at latest time point (3 hours) but was inconsistent in that only the lowest and
highest concentrations showed this effect. However, interestingly, when both
metals were added, LDL was increased at all timepoints, though not to the same
level as LDL treated with NaAsO2 alone. As is known to bind thiol and sulfhydryl
groups, and the ApoB protein contains 25 cysteine residues (Yang et al. 1994),
but it is unknown if As can indeed bind these residues in the LDL molecule.
Similarly, U is known to bind several plasma proteins in vitro, including
ceruloplasmin, complement proteins, and even apolipoprotein A-I (a component
of HDL; Vidaud et al., 2005), but it is unknown how U is interacting with LDL.
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Additionally, we made assumptions that oxidation of LDL by As and U could
occur in the circulation, thereby contributing to atherosclerosis development. It is
unknown if circulating LDL could be directly oxidized by As in vivo. Additionally,
although minimally modified-LDL and ox-LDL are detectable in the circulation,
there is some controversy as to the pathologically-relevant location of LDL
oxidation. It is generally thought that LDL first moves into the vascular intima and
then is modified by ROS and reactive nitrogen species produced by activated
macrophages (Itabe et al., 2011). Metal-ions (e.g. iron or Cu) can sometimes
catalyze the oxidation process (Yoshida and Kisugi, 2010). Thus, assuming LDL
can be modified by toxic metals/As in vivo, it is unknown if LDL oxidation could
occur in the circulation or within developing plaques. Some evidence suggests
that metals selectively accumulate in chronic vascular lesions (Hanć et al. 2011;
Simeonova et al., 2003; Stadler et al. 2004), but it is unknown if As or U present
in developing plaques can potentiate LDL oxidation.

In summary, our results show that water intake of As is associated with oxLDL
but not CRP in a native population. Data from acellular experiments are in line
with our regression modeling in that As, but not U, could oxidatively modify LDL
cholesterol.

Future Directions
Population Studies
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The complexity of human disease, i.e. “multi-morbidity” can make prediction of
outcomes difficult and there are numerous potential confounding variables that
were not included in the analysis. For example, the Navajo population is also
known to have an increased risk of kidney disease associated with mining
proximity (Hund et al. 2015), which may also intersect with cardiovascular
disease prevalence and certainly influence circulating biomarkers. It would be
helpful to assess kidney biomarkers (creatinine, BUN) and include them in our
analyses. Along these lines, it would also be informative to assess liver enzymes
in relation to biomarkers and exposure. As exposure in mice promotes
inflammatory angiogenesis and vessel remodeling in the liver (Straub et al.
2007a, 2007b). As effects on liver vasculature may impair the liver’s ability to
clear modified lipids and modified proteins (Mazumder et al. 2005). It is
important to consider CVD co- and multi-morbidities, as populations with CVDrelated conditions may be more susceptible to environmental toxins. Our study
design did not allow for risk/odds ratios of clinical disease due in part to the
limited size of the cohort and lack of long-term follow-up, but prevalence ratios
could potentially be derived.

Other confounders, such as socioeconomic status, diet, smoking and alcohol use
(already addressed in previous section) could also influence our exposure and
outcomes analysis and we might consider using these potential covariates as
well. However, covariates must be limited to what is relevant to the character of
the population as well as to the number of observations. Furthermore, it is
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doubtful that the range of income and access to health care in this population
would have been sufficiently large to observe a strong influence on CVD
biomarkers.

Alternative means of segregating the study population might also strengthen the
conclusions. It would also be interesting to divide metals exposures, either from
drinking water exposures or urine, into tertiles or quartiles to evaluate potential
non-linear relationships with other response variables (oxLDL, oxLDL ratios,
CRP). We were unable to directly compare co-exposure (e.g. low water As, low
water U; high water As, high water U, etc) groups however due to low power and
a lack of precise data in the low concentration exposure groups.

Finally, it would be informative to recall the DiNEH subset to re-interview and to
obtain blood to follow-up on any long-term changes related to exposure (although
the ongoing Navajo Birth Cohort Study may be addressing some of this). It
would be a particular interest to assess changes in lipid profiles including oxLDL
and perhaps employ an imaging technique (ultrasound to assess carotid intimamedia thickness) to capture lesion development, both to understand the overall
trend of CAD in this population as well as to assess in terms of exposure. It
would also be important to know if exposures via drinking water are stable over
time. Longitudinal study designs strengthen conclusions due to repeated
measures analytical approaches and improved power, in addition to being able to
observe temporal trends.
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Mechanisms of Metal-Induced LDL Oxidation
NaAsO2 increased oxidation of LDL in our experiments and there appeared to be
additive effects when both NaAsO2 and UA were present. Although NaAsO2
could potentially reveal modifiable sites by UA, it seems more likely that the
opposite is true, given that As is known to bind thiol and sulfhydryl groups, and
the ApoB protein contains 25 cysteine residues (Yang et al.1994). U could be
interacting with the apoB protein at sites other than what the antibody can detect
or in a non-oxidative manner, potentially modifying the protein such that
more/fewer oxidation sites are revealed that can be modified by As. A similar
effect has been shown in vitro with aluminum and iron (Kapiotis et al. 2005).
Some of the increased oxidation could be due to the presence of atmospheric
oxygen remaining in the buffer, potentially leading to ROS formation, although we
mitigated this effect by placing the samples under nitrogen flow and sealing
samples before the incubation period.

Several alternative methods might be used to examine LDL oxidation by As (and
U). Conjugated diene formation is a common method used to measure Cuinduced oxLDL. We also might want to determine if other oxidizing LDL protein
modifications are occurring besides what the ELISA antibody can capture by
using a protein-binding assay, such as one that can measure the number of thiol
groups on proteins [5-5’-dithiobis-(2-nitrobenzoic acid)-thiol] (Sedlak and Lindsay
1968). We could also attempt to inhibit or block modifications with a thiol
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compound, anti-oxLDL antibody, or an antioxidant (N-acetylcysteine) to narrow
down how LDL is being modified and to rule out interactions with atmospheric
oxygen in the buffers. We could also try methylated forms As (MMA, DMA) as
these generally have more toxic effects (Aposhian et al. 2003). As an alternative
to measuring MDA, we could use HPLC to evaluate protein adducts of 4hydroxynonenal-amino acid (as opposed to free 4-hydroxynonenal); adducts may
be more stable and offer a “footprint” of past oxidative stress. (Wakita et al. 2011)

Alternatively, the process of LDL oxidation may be an indirect effect of metals
and, while our assays highlight the possibility that As may directly induce oxLDL,
this is not proven in vivo. It has been shown that As can inhibit lipid metabolism
by inhibiting the retinoid X receptor (Padovani et al. 2010), a nuclear receptor
that heterodimerizes with the LXR. LXR is involved in the regulation of
cholesterol transport and efflux and repression of inflammatory genes. LDL
under normal conditions upregulates the ATP-binding cassette transporter (Liao
et al 2002), which interacts with HDL during cholesterol efflux (Weber and Noels
2011). On the other hand, oxLDL has been shown to downregulate ABCA1 by
inhibiting LXR (Zhu 2005). Recently, ABCA1 was found to promote As tolerance
in human cells by reducing cellular As accumulation in ECV304 cells, which
exhibit both endothelial and epithelial characteristics (Tan et al. 2014). Other
studies have demonstrated that As or As-species can be readily taken up by
endothelial cells (Hirano 2003, 2004). Taken together, these studies suggest
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that As and oxLDL each independently lead to inhibition of reverse cholesterol
transport and the accumulation of cholesterol in the vascular wall.

Our results suggest that LDL oxidation could occur directly by toxic metals in
circulation, but this could also reflect what could be occurring within lesions,
which was not addressed in our studies. It would be interesting to test if both As
and lipids could accumulate and possibly co-localize in the vascular wall, which
could lead to excessive cholesterol accumulation and direct oxidation of lipids by
As. This might be one mechanism by which As contributes to chronic CVD.

Accumulation of metals in plaque lesions may enhance oxLDL formation in situ,
and the circulation may be a reflection of this. Lind et al. (2012) found that
circulating levels of Ni, aluminum and chromium were associated with
atherosclerotic plaque sizes or intima-media thickness independently of
cardiovascular risk factors, including lipids in an elderly population. Accumulation
of As was found in cardiovascular tissue by atomic absorption analysis in ApoE-/mice that received 20 or 100 μg/mL sodium As for 24 weeks, and this tissue
accumulation was dose- and time-dependent (Simeonova et al. 2003). Iron has
also been identified in ex vivo human arteries and carotid lesions versus healthy
controls and also correlated with cholesterol levels (Stadler et al. 2004). We
might approach this question by assessing oxLDL formation in blood and aorta
from ApoE-/- mice (or other atherogenic models) exposed to low-to-moderate
concentrations of U and/or As in drinking water. OxLDL levels within
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atheromatous lesions would be measured using anti-oxLDL antibodies and levels
of As and U in these lesions would be assessed by ICP-MS or Raman
spectroscopy (Hanć et al. 2011), and then we would examine any correlations
between these measures. Selective accumulation of metals in human vascular
lesions would be difficult to assess, although postmortem studies or analysis of
coronary arterial resections from patients undergoing coronary artery bypass
grafts might allow for translational evidence of metal impacts.

III.

Cumulative Circulatory Inflammatory Potential and Mine Site

Exposures
Conclusion
Our objective was to examine whether indices of mine waste exposure could
induce circulating inflammatory potential. To accomplish this, we assessed
mRNA expression of inflammatory adhesion molecules and a chemokine in
endothelial cells treated with serum from the DiNEH subset. We then used linear
regression to assess if the mRNA transcriptional changes were correlated with
exposure (metals intake, AUM). We found that AUM proximity was a strong,
independent predictor of endothelial transcriptional responses to the serum, in
terms of mRNA expression of CCL2, ICAM-1, and VCAM-1. All other covariates
including water intake variables and CVD-risk factors (age, gender, BMI, and
HbA1c) were not significant predictors of endothelial responses in the model.

Future Directions
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Our results indicate that other routes of exposure should be considered besides
that of water intake and likely could be airborne transport of contaminated dusts
or uptake of metals into trees, which then might become a wintertime indoor
exposure risk as firewood. In addition, these findings may reflect that it is an
overall exposure to a mixture of metals may be responsible for the circulating
inflammatory potential. Several approaches could be used to address these
potential causes, for instance, mice could be exposed (via inhalation of instillation
methods) to dust samples collected at various AUM proximities. Then the same
inflammatory potential experiments could then be performed using serum from
the mice (as well as several CVD and pulmonary endpoints). Furthermore, these
techniques could be applied to a chronic time course to assess not only
inflammatory markers, but also progression of cardiovascular pathology in
specific mouse models. However, mice might not respond the same way as
humans, therefore further epidemiological studies would be desirable that could
somehow stratify different levels of exposure or obtain more serum to conduct a
larger-scale, longitudinal study that included follow-up and access to medical
records.

Serum represents the balance of pro- and anti-inflammatory circulating factors.
In inflammatory CVD disease states and exposure scenarios, the serum is more
atherogenic, and anti-inflammatory and athero-protective components would be
reduced (Gowri et al 1999; Vergès 2009;). Most responses by the endothelium
in this assay are assumed to be receptor-mediated leading to transcriptional
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responses. Therefore, we have measured transcriptional levels of several proinflammatory molecules (ICAM-1, VCAM-1, CCL2, and interleukin-8) in this and
other studies (Channell et al. 2012; Cung et al. 2015). In a slightly different study
design, healthy subjects receiving grape seed extract (principally the polyphenol,
resveratrol) for a month exhibited reduced inflammatory potential in their serum,
compared to subjects taking placebo (Agarwal, Campen et al., 2013). This study
suggests that the inflammatory potential of the serum is a sensitive metric of the
net balance of pro- and anti-inflammatory factors, as healthy subjects revealed
benefits of a nutraceutical (inflammatory cytokines were measured, but remained
unchanged). Furthermore, this study asserts that the serum inflammatory
potential is, in fact, modifiable.

In a similar vein, the effects of a more “ideal” serum inflammatory status could be
obtained from trained humans (or rodents) involved in exercise studies, since
exercise is known to reduce inflammation both acutely and over time (Gleeson et
al. 2011; Neefkes-Zonneveld et al. 2015). In this case, we could perform the
same experiments but expect reduced transcription of inflammatory mRNA and
vice versa. Conducting intervention studies of exercise with the Navajo
population affected by the AUM exposures may not directly explain the
mechanism underlying the exposure-related insult to the cardiovascular system,
but it would offer suggestions as to how lifestyle factors may help overcome
environmental health risks.
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The overall approach of using endothelial cells as a biomarker of circulating
inflammatory state offers further opportunities to better understand the
mechanisms and potential health outcomes. Some studies have suggested that
NFκB, a major transcription factor that regulates inflammatory processes, can be
induced in arsenite-exposed macrophages and endothelial cells through
oxidative stress (Barchowsky et al. 1996; Hossain et al. 2013). Serum from
humans exposed to diesel emissions was able to induce a profile of endothelial
transcriptional changes consistent with NFκB activation (Schisler et al., 2015).
To determine if NFκB is indeed mediating the responses seen in the present
study, endothelial cells could be treated with exposed and unexposed serum
(from humans or mice with appropriate cell type), and then NFκB activation
(activated p50, p65 transcription factors, luciferase-linked promoter assay) could
be measured. Alternatively, an NFκB inhibitor could be added to the serumtreatment (serum with and without the inhibitor, or exposed serum with and
without the inhibitor), and then measure if transcriptional responses are inhibited.
In a similar vein, numerous possibilities exist to mechanistically probe the role of
other transcriptional or cell signaling pathways activated by serum components.

Changes in expression that occur following chemical exposure may also be
adaptive responses (Dangleben 2013), and naïve endothelial cells may not
respond in the same way as endothelial cells from chronically exposed humans.
Therefore, we should also attempt to design studies that assess more chronic
exposures to serum treatment. One way to do this might be to repeatedly
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serum-treat endothelial cells over several days and then assess responses. It is
also possible to collect and isolate endothelial cells from freshly obtained human
blood for culture work, although this would be highly challenging in community
studies. Indirect measures of endothelial function, such as brachial artery flow,
vascular stiffness, or hyperemic responses might be more feasible in the field.

A direct link between exposure to As and other metals and endothelial
dysfunction and inflammation in humans has not been thoroughly investigated
(Stea et al. 2014). Our study has attempted to fill this gap. AUM proximity was
the only predictor of inflammatory endothelial cell transcriptional responses to
serum from exposed Navajo participants. These results have potentially opened
a new avenue of exploring airborne sources of toxicity in this community. This
novel inflammatory potential assay promises to be very useful and has many
potential applications experimentally, and maybe eventually clinically. Chronic
exposures to mining wastes may potentiate increasing inflammatory-related
health conditions in this population.

SUMMARY AND CONCLUSIONS
In summary, the results from these studies suggest that there are potential CV
effects from AUM-related exposures in a subset of the DiNEH survey
participants, a highly underserved population with numerous CVD risk factors.
We used several exposure metrics in our regression modeling including
estimated annual water intakes, AUM proximity and urine metals, which
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represent different exposure sources and pathways, and each had differing
effects depending on the variable that was measured. Thus, certain exposure
metrics may be more important at varying points along the continuum of
atherogenesis. This work is also important because we included individual
measures of exposure which is often lacking in many population toxicity studies.

Results from the inflammatory potential assay also suggest that there is a
broader effect of mining waste on circulating inflammatory status than just
drinking water exposure alone on a single circulating CV biomarker (oxLDL).
Underlying health conditions could increase susceptibility to these exposures,
and inflammation plays an important role in the pathogenesis of many health
conditions that could be affected by these exposures. Thus, other routes of
exposure, such as airborne transport and food consumption, as well as other
metals and metal mixtures should be considered in future studies that include
long-term CV outcomes.

As U and other metals continue to be mined throughout the world, with more
mining operations in production due to an ever increasing demand (Organization
for Economic Co-operation and Development 2014; Rogich and Matos 2008),
many populations will continue to be exposed to mining waste from both current
and historical operations. It is imperative to continue investigating the health
effects of these exposures because the knowledge gained could guide
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environmentally and socially responsible mining practices and clinical treatment
decisions in affected communities.
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